Home Cart Sign in  
Chemical Structure| 936563-96-1 Chemical Structure| 936563-96-1

Structure of Ibrutinib
CAS No.: 936563-96-1

Chemical Structure| 936563-96-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ibrutinib (PCI-32765) is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM.

Synonyms: PCI-32765; Imbruvica; PCI32765, PCI-32765, PCI 32765, Ibrutinib, Imbruvica

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ibrutinib

CAS No. :936563-96-1
Formula : C25H24N6O2
M.W : 440.50
SMILES Code : C=CC(N1CCC[C@@H](N2C3=C(C(N)=NC=N3)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=N2)C1)=O
Synonyms :
PCI-32765; Imbruvica; PCI32765, PCI-32765, PCI 32765, Ibrutinib, Imbruvica
MDL No. :MFCD20261150
InChI Key :XYFPWWZEPKGCCK-GOSISDBHSA-N
Pubchem ID :24821094

Safety of Ibrutinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Ibrutinib

RTK

Isoform Comparison

Biological Activity

Target
  • BTK

    BTK, IC50:0.5 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Human MDSC 1 μM 1 h Ibrutinib treatment resulted in a decrease in the level of p-BTK. PMC4873459
Human chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) cell lines 1 μM Enhanced AID expression and translocation frequency PMC5382874
Mouse B cells 1 μM Enhanced AID expression, increased somatic hypermutation (SHM) and chromosomal translocation frequency PMC5382874
MSC2 cells 0.01 μM to 1 μM 1 h Inhibited BTK phosphorylation, even at the 0.01 μM dose in the presence or absence of LPS stimulation. PMC4873459
U87 cells 0, 5, 10 μM 10 days Ibrutinib inhibited the proliferation and migration of LN229 and U87 cells, and induced apoptosis and autophagy. PMC5513110
LN229 cells 0, 5, 10 μM 10 days Ibrutinib inhibited the proliferation and migration of LN229 and U87 cells, and induced apoptosis and autophagy. PMC5513110
Primary microglial cells 1 μM 30 min Ibrutinib significantly downregulated the LPS-mediated increases in the levels of the mRNAs encoding the proinflammatory cytokines COX-2 and IL-6. PMC6145206
BV2 microglial cells 1 μM 30 min Ibrutinib significantly reduced LPS-induced increases in proinflammatory cytokine levels and regulated TLR4 signaling, decreasing p-AKT and p-STAT3 levels, suggesting that ibrutinib attenuates LPS-induced neuroinflammatory responses by inhibiting AKT/STAT3 signaling pathways. PMC6145206
HL60/Adr 5 μM 72 hours To evaluate the reversal effect of PCI 29732 on MRP1-mediated multidrug resistance, results showed that PCI 29732 significantly enhanced the cytotoxicity of MRP1 substrate drugs PMC4290721
HEK293/MRP1 5 μM 72 hours To evaluate the reversal effect of PCI 29732 on MRP1-mediated multidrug resistance, results showed that PCI 29732 significantly enhanced the cytotoxicity of MRP1 substrate drugs PMC4290721

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Pristane-induced plasma cell (PC) tumor model Oral 10 mg/kg Once daily for 70 days Increased the formation of AID-dependent tumors PMC5382874
Mice P53ER/ER;LSLKRasG12D;Pdx1-cre mice Drinking water 0.16 mg/mL Daily for 4 weeks Ibrutinib significantly diminished fibrosis, extended survival, and improved the response to clinical standard-of-care therapy. PMC6773609
Mice EMT6 mammary tumor model Drinking water 25 mg/kg Daily, for two weeks Ibrutinib treatment significantly reduced the frequency of MDSCs in both the spleen and tumor, and improved the efficacy of anti-PD-L1 checkpoint blockade. PMC4873459
BALB/C nude mice U87 xenograft model Intraperitoneal injection 6 mg/kg Every other day, for 22 days Ibrutinib induced autophagy and exerted antitumor effect in the U87 xenograft model, and the combination of 3MA with Ibrutinib enhanced the antitumor effect. PMC5513110
Wild-type mice Wild-type mice Intraperitoneal injection 10 mg/kg Daily for 3 days Ibrutinib significantly reduced LPS-induced microglial/astrocyte activation and COX-2 and IL-1β proinflammatory cytokine levels. PMC6145206
Nude mice HEK293/MRP1 cell xenograft model Oral 30 mg/kg Every other day for 7 days To evaluate the inhibitory effect of PCI 29732 combined with vincristine on the growth of MRP1-overexpressing tumors, results showed that the combination therapy significantly inhibited tumor growth PMC4290721

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02824029 Classical Hodgkin Lymphoma ... More >> Recurrent Hodgkin Lymphoma Refractory Hodgkin Lymphoma Less << Phase 2 Recruiting February 2019 United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Radhakrishnan Ramchandren    313-576-8739       Principal Investigator: Radhakrishnan Ramchandren, M.D.          Sub-Investigator: Divaya Bhutani, M.D.          Sub-Investigator: Jay Yang, M.D.          Sub-Investigator: Jeffrey Zonder, M.D.          Sub-Investigator: Charles Schiffer, M.D.          Sub-Investigator: Abhinav Deol, M.D.          United States, Texas M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Michelle A. Fanale    713-792-2860    mfanale@mdanderson.org    Principal Investigator: Michelle A. Fanale Less <<
NCT03021460 Metastatic Melanoma ... More >> Stage III Skin Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Recruiting February 1, 2021 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Matthew S. Block Less <<
NCT02899078 Metastatic Renal Cell Cancer ... More >> Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Recruiting May 2020 United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Primo N. Lara, M.D.    916-734-3771    pnlara@ucdavis.edu    Principal Investigator: Primo N. Lara, M.D.          Sub-Investigator: Chong-Xian Pan, M.D., Ph.D. Less <<
NCT03379428 Breast Neoplasms ... More >> Malignant Neoplasm of Breast Less << Phase 1 Phase 2 Recruiting December 2021 United States, Texas ... More >> 10 sites incl TX, WA, VA, and NV Recruiting Dallas, Texas, United States, 75246 Contact: Site Research Coordinator Less <<
NCT03617484 Mantle Cell Lymphoma Phase 2 Not yet recruiting September 2021 United States, Michigan ... More >> University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States, 48187 Less <<
NCT01833039 Relapsed or Refractory Mantle ... More >>Cell Lymphoma Less << APPROVED_FOR_MARKETING - Phoenix, Arizona, United State... More >>s|Duarte, California, United States|Los Angeles, California, United States|Stanford, California, United States|Denver, Colorado, United States|Norwalk, Connecticut, United States|Stamford, Connecticut, United States|Washington, District of Columbia, United States|Miami Beach, Florida, United States|Ocala, Florida, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Springfield, Illinois, United States|Goshen, Indiana, United States|Sioux City, Iowa, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Worcester, Massachusetts, United States|Detroit, Michigan, United States|Rochester, Minnesota, United States|Jefferson City, Missouri, United States|Saint Louis, Missouri, United States|Lincoln, Nebraska, United States|Omaha, Nebraska, United States|Reno, Nevada, United States|Hackensack, New Jersey, United States|New Hyde Park, New York, United States|New York, New York, United States|Syracuse, New York, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Watertown, South Dakota, United States|Knoxville, Tennessee, United States|Austin, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Burlington, Vermont, United States|Morgantown, West Virginia, United States|Barretos, Brazil|Florianopolis, Brazil|Porto Alegre, Brazil|Rio de Janeiro, Brazil|Salvador, Brazil|Sao Paulo, Brazil|San Juan, Puerto Rico Less <<
NCT02626884 Nodular Lymphocyte-Predominant... More >> Hodgkin's Lymphoma Less << PHASE2 COMPLETED 2025-08-20 1st Department of Medicine, Co... More >>logne University Hospital, Cologne, Germany Less <<
NCT02662296 Prolymphocytic Leukemia ... More >> Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Less << Phase 2 Withdrawn(Low enrollment) - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03581942 Refractory/Recurrent Primary C... More >>entral Nervous System Lymphoma (PCNSL) Less << Phase 1 Phase 2 Recruiting July 2021 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Christian Grommes, MD    212-639-4058       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Christian Grommes, MD    212-639-4058       Contact: Ingo Mellinghoff, MD    646-888-2766 Less <<
NCT02537613 Chronic Lymphocytic Leukemia Phase 1 Recruiting August 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jeremy Abramson, MD    617-724-4000    jabramson@partners.org    Principal Investigator: Jeremy Abramson, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Matthew Davids, MD    617-632-6331    matthew_davids@dfci.harvard.edu    Principal Investigator: Matthew Davids, MD          United States, New York University of Rochester Wilmot Cancer Inst. Recruiting Rochester, New York, United States, 14642 Contact: Paul Barr, MD       paul_barr@urmc.rochester.edu    United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Danielle Brander, MD       danielle.brander@duke.edu Less <<
NCT01569750 CD20-positive B-cell Non-Hodgk... More >>in Lymphoma Less << Phase 1 Completed - United States, New York ... More >> New York, New York, United States Rochester, New York, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States France Lille Cedex, France Paris, France Vandoeuvre Les Nancy, France Less <<
NCT02542514 Primary Central Nervous Lympho... More >>ma|Intraocular Lymphoma Less << PHASE2 COMPLETED 2021-12-01 CHU d'ESTAING, Clermont Ferran... More >>d, France|CHU de Grenoble, Grenoble, France|CHRU de LILLE - Claude Huriez, Lille, France|Centre Léon Bérard, Lyon, France|CHU de la Pitié Salpêtrière, Paris, France|CHU de la Timone, Paris, France|CHU de Rennes, Rennes, France|Centre Henri Becquerel, Rouen, France|H?pital René Huguenin Institut Curie, Saint-Cloud, France|CHU Brabois, Vandoeuvre les Nancy, France Less <<
NCT03710772 CD20 Positive ... More >> Mantle Cell Lymphoma Less << Phase 2 Not yet recruiting May 18, 2023 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Luhua (Michael) Wang    713-792-2860       Principal Investigator: Luhua (Michael) Wang Less <<
NCT02207062 Recurrent B-Cell Non-Hodgkin L... More >>ymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-288-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT03267186 Acute Biphenotypic Leukemia ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic Cell Transplantation Recipient Less << Phase 2 Recruiting March 2020 United States, California ... More >> Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Physician Referrals    650-723-0822       Principal Investigator: Andrew Rezvani Less <<
NCT03128879 Primary Lymphoid Haematopoieti... More >>c Neoplasms Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Less << Phase 2 Recruiting June 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       pathompson2@mdanderson.org Less <<
NCT01779791 Lymphoma Phase 2 Completed - -
NCT02200848 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 1 Terminated(Recruitment difficu... More >>lties and toxicity) Less << - United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT03093831 Lymphoma, B-Cell, Marginal Zon... More >>e Less << PHASE2 TERMINATED 2020-07-17 Singapore General Hospital, Si... More >>ngapore, 169608, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore Less <<
NCT02623010 Central Nervous System Lymphom... More >>a Less << PHASE2 UNKNOWN 2025-12-23 Hematology Institute, Petah Ti... More >>kva, 494192, Israel Less <<
NCT03301207 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Active, not recruiting January 20, 2019 Poland ... More >> Malopolskie Centrum Medyczne Krakow, Poland, 30-510 Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu Wroclaw, Poland, 50-367 Spain Hosp. Univ. Fund. Jimenez Diaz Madrid, Spain, 28040 Clinica Univ. de Navarra Pamplona, Spain, 31008 Less <<
NCT02841150 Healthy Phase 1 Completed - United States, Arizona ... More >> Tempe, Arizona, United States Less <<
NCT02863718 Chronic Lymphocytic Leukemia Phase 3 Recruiting April 2022 Germany ... More >> German CLL Study Group Recruiting Cologne, Germany, 50935 Contact: Berit Mahr    +49 221 478 88220       Principal Investigator: Petra Langerbeins, MD Less <<
NCT03323151 Mantle-Cell Lymphoma Phase 1 Phase 2 Recruiting December 2024 United States, Georgia ... More >> Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Vanessa Smith    404-778-2214    vanessa.smith@emory.edu    Contact: Terra Burney    404-712-0465    terra.l.burney@emory.edu    Principal Investigator: Jonathon Cohen, MD          United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Oniel Padilla Escalera, MPH    732-235-5972    op100@cinj.rutgers.edu    Contact: Dama Bhavsar    732-235-6008    bhavsadm@cinj.rutgers.edu    Principal Investigator: Kevin David, MD          United States, New York Laura and Isaac Perlmutter Cancer Center at NYU Recruiting New York, New York, United States, 10016 Contact: Angela Tan    646-501-7869    angela.tan@nyumc.org    Contact: Nancy Doan    646-501-7921    nancy.doan@nyumc.org    Principal Investigator: Catherine Diefenbach, MD          United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Joseph Vena    215-584-3073    joseph.vena@uphs.upenn.edu    Contact: Shannon Cosgrove    215-220-9632    shannon.cosgrove@uphs.upenn.edu    Principal Investigator: Daniel Landsburg, MD          Reading Hospital/McGlinn Cancer Institute Recruiting West Reading, Pennsylvania, United States, 19611 Contact: Barbara Miller, RN    484-628-8549    barbara.miller@towerhealth.org    Contact: Janet Knoblauch, RN    484-628-9376    janet.knoblauch@towerhealth.org    Principal Investigator: Terrence Cescon, MD          United States, Virginia University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Erica Stallard    434-243-2649    Elg9r@hscmail.mcc.vriginia.edu    Contact: Kimberly Underwood    434-982-3947    Km3q@hscmail.mcc.virginia.edu    Principal Investigator: Craig Portell, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Sylvia McEwuen    304-293-1683    smcewuen@hsc.wvu.edu    Contact: Valerie Phillips    304-581-1880    vphillip@hsc.wvu.edu    Principal Investigator: Abraham Kanate, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53792 Contact: Kaitlin Chambers    608-263-5006    kchambers2@wisc.edu    Contact: Craig Augustine    608-265-5542    cfaugustine@wisc.edu    Principal Investigator: Christopher Fletcher, MD          Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Katelyn Gauger    414-805-4587    kgauger@mcw.edu    Contact: Kristin Mikulice    414-805-4627    kmikulice@mcw.edu    Principal Investigator: Mehdi Hamadani, MD          ProHealth Care Recruiting Waukesha, Wisconsin, United States, 53188 Contact: Chanda Miller    262-928-5539    chanda.miller@phci.org    Contact: Amelia Crouse    262-928-2143    amelia.crouse@phci.org    Principal Investigator: Timothy Wassenaar, MD Less <<
NCT02677948 Chronic Lymphocytic Leukemia ... More >> Lymphoma, Small Lymphocytic Less << Phase 1 Phase 2 Withdrawn(FDA has placed all t... More >>rials involving Pacritinib on Full Clinical Hold) Less << October 2018 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02689869 Indolent Non-Hodgkin Lymphoma Phase 2 Active, not recruiting July 2022 Germany ... More >> Klinikum der Universität München München, Bavaria, Germany, 81377 Less <<
NCT02956382 Refractory Follicular Lymphoma... More >> Relapsed Follicular Lymphoma Less << Phase 1 Phase 2 Recruiting November 2021 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Pari Ramzi, RN    202-784-0038    ramzip1@georgetown.edu    Principal Investigator: Bruce Cheson, MD          United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara Yannotti, BSN    551-996-5168    Kara.Yannotti@HackensackMeridian.org    Contact: Sabrina Kdiry, BSN    551-996-5952    Sabrina.Kdiry@HackensackMeridian.org    Principal Investigator: Lori Ann Leslie, MD Less <<
NCT01626651 Healthy Phase 1 Completed - United States, New Jersey ... More >> Neptune, New Jersey, United States Less <<
NCT03425591 Leukemia, Lymphocytic, Chronic... More >>, B-Cell|Lymphoma, Mantle-Cell Less << COMPLETED 2022-08-11 Paris Cedex 13, France
NCT02756897 Chronic Lymphocytic Leukemia ... More >> Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma Untreated Chronic Lymphocytic Leukemia Untreated Small Lymphocytic Lymphoma Less << Phase 2 Recruiting July 1, 2024 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nitin Jain    713-745-6080       Principal Investigator: Nitin Jain Less <<
NCT01614821 Waldenstrom's Macroglobulinemi... More >>a Less << PHASE2 COMPLETED 2018-09-15 Stanford University, Palo Alto... More >>, California, 94305, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States Less <<
NCT02055924 B-cell Lymphoma Phase 1 Terminated(ANSM decision due t... More >>o veino occlusive disease (security alert)) Less << - Belgium ... More >> Universite Catholique de Louvain Saint Luc Bruxelles, Belgium CHU de Liège Liège, Belgium, 04000 CHU UCL Namur asbl Yvoir, Belgium, 5530 France Centre François Baclesse Caen, France, 14076 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21034 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Montpellier Montpellier, France, 34295 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 Centre François Magendie - Hôpital du Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT02109224 Adult B Acute Lymphoblastic Le... More >>ukemia Chronic Lymphocytic Leukemia Cutaneous B-Cell Non-Hodgkin Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue HIV Infection Intraocular Lymphoma Multicentric Angiofollicular Lymphoid Hyperplasia Nodal Marginal Zone Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Plasma Cell Myeloma Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Terminated(Inadequate accrual ... More >>rate) Less << - United States, California ... More >> UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States, 90035 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02902965 Multiple Myeloma Phase 2 Completed - Czechia ... More >> Fakultní nemocnice Brno Brno, Czechia Fakultní nemocnice Hradec Králové Nový Hradec Králové, Czechia Fakultní nemocnice Ostrava Ostrava-Poruba, Czechia Všeobecná fakultní nemocnice v Praha Praha 2, Czechia Germany Helios-Kliniken Berlin-Buch Berlin, Germany Vivantes Klinikum Spandau Berlin, Germany Universitätsklinikum Jena Jena, Germany Klinikum der Universität München Campus Grosshadern München, Germany Greece 251 General Air Force Hospital Athens, Greece General Hospital of Athens "Alexandra" Athens, Greece General Hospital of Athens "Evangelismos" Athens, Greece General Hospital of Athens "LAIKO" Athens, Greece University General Hospital of Patra Patras, Greece General Hospital of Thessaloniki "G. Papanikolau" Thessaloniki, Greece Italy IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Bologna, Italy Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori Meldola (FC), Italy Ospedale Santa Maria delle Croci Ravenna, Italy Ospedale degli Infermi Rimini, Italy Azienda Ospedaliera S. Maria di Terni Terni, Italy Spain Hospital Universitario Rey Juan Carlos Mostoles, Madrid, Spain Complejo Hospitalario Universitario A Coruña A Coruna, Spain ICO Badalona-Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital Universitario Madrid Sanchinarro Madrid, Spain Clinica Universidad de Navarra Pamplona, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario Virgen del Rocio Sevilla, Spain Hospital Universitario Dr. Peset Valencia, Spain Turkey Ankara University Medical Faculty Ankara, Turkey Dokuz Eylul University Medicine Faculty Izmir, Turkey Erciyes University Medical Faculty Kayseri, Turkey Ondokuz Mayis Univ. Med. Fac. Samsun, Turkey Less <<
NCT02381080 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 1 Completed - Canada ... More >> N/a N/a, Canada Russian Federation Moscow, Russian Federation Petrozavodsk, Russian Federation St. Petersburg, Russian Federation Spain Madrid, Spain Pamplona, Spain Less <<
NCT03130348 Amyloidosis I... More >>mmunoglobulin Light Chain Deposition Less << Phase 2 Withdrawn(Study was dropped at... More >> site before participation) Less << April 2022 -
NCT02991638 Chronic Lymphocytic Leukemia|I... More >>ndolent B-cell Lymphomas|Chronic Hepatitis B|Lymphoma, Small Lymphocytic|Mantle-Cell Lymphoma|Waldenstrom's Macroglobulinaemia|Follicular Lymphoma Less << PHASE3 UNKNOWN 2025-06-21 The University of Hong Kong, H... More >>ong Kong, Hong Kong Less <<
NCT02670317 Lymphoma, B-Cell Phase 2 Terminated(GA101-CHOP not adva... More >>ntage from rituximab-CHOP) Less << - Italy ... More >> IRCCS Candiolo - Fondazione del Piemonte per l'oncologia Candiolo, TO, Italy AO SS. Antonio e Biagio e C. Arrigo Alessandria, Italy, 15121 AOU Policlinico Consorziale Bari, Italy AO Papa Giovanni XXIII Bergamo, Italy Ospedale di Bolzano Bolzano, Italy Ospedale Businco Cagliari, Italy AO di Cosenza Cosenza, Italy AOU Careggi Firenze, Italy P.O. Vito Fazzi Lecce, Italy IRST Meldola Meldola, Italy Ospedale Papardo Messina, Italy Istituto Europeo Oncologico Milano, Italy AOU Policlinico di Modena Modena, Italy Ospedale San Gerardo Monza, Italy IRCCS Napoli Pascale Napoli, Italy Ospedale Maggiore della Carità Novara, Italy AOOR Villa Sofia Cervello Palermo, Italy AOU di Parma Parma, Italy Ospedale G. Da Saliceto Piacenza, Italy AOR San Carlo Potenza, Italy Ospedale Degli Infermi Rimini, Italy Policlinico Gemelli Roma, Italy Policlinico Umberto I Roma, Italy Humanitas Rozzano, Italy Casa Sollievo della Sofferenza San Giovanni Rotondo, Italy AOU Città Della Salute e Della Scienza Ematologia Universitaria Torino, Italy AOU Città Della Salute e Della Scienza SC Ematologia Torino, Italy AOU di Udine Udine, Italy Ospedale di Circolo e Fondazione Macchi Varese, Italy Less <<
NCT02553941 Chronic Myelomonocytic Leukemi... More >>a de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Secondary Myelodysplastic Syndrome Less << Phase 1 Recruiting November 2020 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Gary J. Schiller    888-798-0719    garyjs@ucla.edu    Principal Investigator: Gary J. Schiller          UC Irvine Health/Chao Family Comprehensive Cancer Center Active, not recruiting Orange, California, United States, 92868 University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian A. Jonas    916-734-3772    bajonas@ucdavis.edu    Principal Investigator: Brian A. Jonas          University of California San Diego Recruiting San Diego, California, United States, 92103 Contact: Matthew J. Wieduwilt    858-822-5354    cancercto@ucsd.edu    Principal Investigator: Matthew J. Wieduwilt          University of California, San Francisco Recruiting San Francisco, California, United States, 94118 Contact: Aaron C. Logan    415-502-2110    aclogan@medicine.ucsf.edu    Principal Investigator: Aaron C. Logan Less <<
NCT02877225 Healthy Phase 1 Completed - United States, Arizona ... More >> Tempe, Arizona, United States Less <<
NCT03734016 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Recruiting October 2025 United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada - USOR Recruiting Las Vegas, Nevada, United States, 89169 Principal Investigator: Edwin Kingsley, MD          United States, New Jersey Summit Medical Group Recruiting Florham Park, New Jersey, United States, 07932 Principal Investigator: Charles Farber, MD          United States, New York Clinical Research Alliance Inc Recruiting Lake Success, New York, United States, 11042 Principal Investigator: Morton Coleman, MD          United States, Washington Medical Oncology Associates Recruiting Spokane, Washington, United States, 99208 Principal Investigator: Arvind Chaudhry Less <<
NCT02388048 Leukemia, Lymphoblastic, Chron... More >>ic Less << Phase 2 Recruiting November 2020 Italy ... More >> Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Recruiting Roma, Provincia, Italy, 00141 Contact: Francesca R. Mauro          Principal Investigator: Francesca R. Mauro          S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Daniela Pietrasanta          Principal Investigator: Daniela Pietrasanta          Sub-Investigator: Elisa Bernocco          Nuovo Record Esporta in Excel Stampa Esporta in file di testo Mostra Informazioni Record Multi edit Stato dello studio presso il centro records: 28 Record 1/28 su 28 direzione di ordinamento Centro (CIC) direzione di ordinamento Sperimentatore Pri Not yet recruiting Bologna, Italy Contact: Pierluigi Zinzani          Principal Investigator: Pierluigi Zinzani          Sub-Investigator: Vittorio Stefoni          ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Recruiting Cagliari, Italy Contact: Roberta Murru          Principal Investigator: Roberta Murru          Sub-Investigator: Stefania Massidda          Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Recruiting Catania, Italy Contact: Francesco Di Raimondo          Principal Investigator: Francesco Di Raimondo          Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Recruiting Catanzaro, Italy Contact: Stefano Molica          Principal Investigator: Stefano Molica          Sub-Investigator: Rosanna Mirabelli          Nuovo Record Esporta in Excel Stampa Esporta in file di testo Mostra Informazioni Record Multi edit Stato dello studio presso il centro records: 28 Record 1/28 su 28 direzione di ordinamento Centro (CIC) direzione di ordinamento Sperimentatore Pri Recruiting Cona, Italy Contact: Antonio Cuneo          Principal Investigator: Antonio Cuneo          Sub-Investigator: Gian Matteo Rigolin          U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza Recruiting Cosenza, Italy Contact: Fortunato Morabito          Principal Investigator: Fortunato Morabito          Sub-Investigator: Massimo Gentile          Policlinico di Careggi Not yet recruiting Firenze, Italy Contact: Alberto Bosi          Principal Investigator: Alberto Bosi          Sub-Investigator: Stefania Ciolli          IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente Not yet recruiting Genova, Italy Contact: Angelo Michele Carella          Principal Investigator: Angelo Michele Carella          ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Recruiting Lecce, Italy Contact: Nicola Di Renzo          Principal Investigator: Nicola Di Renzo          Sub-Investigator: Maria Raffaela Fadda          Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Recruiting Meldola, Italy Contact: Sonia Ronconi          Principal Investigator: Sonia Ronconi          Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" P.O. Papardo Recruiting Messina, Italy Contact: Donato Mannina          Principal Investigator: Donato Mannina          Sub-Investigator: Laura Nocilli          Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano Recruiting Milano, Italy Contact: Marco Montillo          Principal Investigator: Marco Montillo          S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Recruiting Novara, Italy Contact: Ginlunca Gaidano          Principal Investigator: Gianluca Gaidano          Sub-Investigator: Lorenzo De Paoli          U.O. di Ematologia con trapianto - Centro di Riferimento Regionale per le coagulopatie rare nel bambino e nell'adulto Dipart. Biomedico di Medicina Interna - A.U. Policlinico "Paolo Giaccone" Not yet recruiting Palermo, Italy Contact: Sergio Siragusa          Principal Investigator: Sergio Siragusa          Sub-Investigator: Maria Grazia Lipari          Cattedra di Ematologia CTMO Università degli Studi di Parma Not yet recruiting Parma, Italy Contact: Francesca Re          Principal Investigator: Francesca Re          Sub-Investigator: Filomena Russo          Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia Recruiting Perugia, Italy Contact: Brunangelo Falini          Principal Investigator: Brunangelo Falini          Sub-Investigator: Franca Falzetti          U.O. Ematologia Clinica - Azienda USL di Pescara Not yet recruiting Pescara, Italy Contact: Francesco Angrilli          Principal Investigator: Francesco Angrilli          Sub-Investigator: Erica Finolezzi          Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci          Principal Investigator: Fiorella Ilariucci          Sub-Investigator: Isabel Alvarez          Ospedale "Infermi" Recruiting Rimini, Italy Contact: Anna Lia Molinari          Principal Investigator: Anna Lia Molinari          Sub-Investigator: Patrizia Tosi          Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Not yet recruiting Roma, Italy Contact: Luca Laurenti          Principal Investigator: Luca Laurenti          Sub-Investigator: Idanna Innocenti          Università degli Studi - Policlinico di Tor Vergata Not yet recruiting Roma, Italy Contact: Sergio Amadori          Principal Investigator: Sergio Amadori          Sub-Investigator: Maria Ilaira Del Principe          A.O. Santa Maria - Terni S.C Oncoematologia Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          Sub-Investigator: Ilaria Angeletti          A.O. Mauriziano Umberto I Recruiting Torino, Italy Contact: Massimo Massaia          Principal Investigator: Massimo Massaia          Sub-Investigator: Daniela Gottardi          Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Lorella Orsucci          Principal Investigator: Lorella Orsucci          Sub-Investigator: Carola Boccomini          Divisione di Ematologia dell' Università degli Studi di Torino - "Città della Salute e della Scienza di Torino" Not yet recruiting Torino, Italy Contact: Marta Coscia          Principal Investigator: Marta Coscia          Sub-Investigator: Benedetto Bruno          Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Recruiting Verona, Italy Contact: Dino Veneri          Principal Investigator: Dino Veneri          Sub-Investigator: Emanuele Guardalben Less <<
NCT02415608 Aggressive Systemic Mastocytos... More >>is|Mast Cell Leukemia|Systemic Mastocytosis Less << PHASE2 TERMINATED 2017-06-14 Stanford University Hospitals ... More >>and Clinics, Stanford, California, 94305, United States Less <<
NCT02966730 Follicular Lymphoma|Follicular... More >> Lymphoma, Grade 1|Follicular Lymphoma, Grade 2|Follicular Lymphoma Grade IIIa Less << EARLY_PHASE1 TERMINATED 2019-06-20 Memorial Sloan Kettering Baski... More >>ng Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan - Kettering Cancer Center, New York, New York, 10021, United States|Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States Less <<
NCT03225716 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 1 Phase 2 Recruiting January 31, 2025 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven P. Treon, MD, PhD    617-632-2681    steven_treon@dfci.harvard.edu    Principal Investigator: Steven P. Treon, MD, PhD Less <<
NCT02415608 Aggressive Systemic Mastocytos... More >>is|Mast Cell Leukemia|Systemic Mastocytosis Less << PHASE2 TERMINATED 2017-06-14 Stanford University Hospitals ... More >>and Clinics, Stanford, California, 94305, United States Less <<
NCT02682641 Mantle Cell Lymphoma Phase 2 Recruiting January 2023 Spain ... More >> Hospital Universitario Mútua Terrassa Recruiting Terrassa, Barcelona, Spain Contact: Ana Muntañola, MD          Principal Investigator: Ana Muntañola, MD          Hospital Universitario Fundación Alcorcón Recruiting Alcorcón, Madrid, Spain Contact: Francisco Javier Peñalver, MD          Principal Investigator: Francisco Javier Peñalver, MD          Hospital General Universitario Santa Lucía Recruiting Cartagena, Murcia, Spain Contact: Marta Romera, MD          Principal Investigator: Marta Romera, MD          Hospital Costa del Sol Recruiting Marbella, Málaga, Spain Contact: María Casanova, MD          Principal Investigator: María Casanova, MD          Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Eva Giné, MD          Principal Investigator: Eva Giné, MD          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain Contact: Javier Briones, MD          Principal Investigator: Javier Briones          Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain Contact: Ana Marín, MD          Principal Investigator: Ana Marín, MD          Institut Català d'Oncologia Recruiting Barcelona, Spain Contact: Eva González Barca, MD          Principal Investigator: Eva González Barca, MD          Hospital Universitario de Burgos Recruiting Burgos, Spain Contact: Tomás José González-Lopez, MD          Principal Investigator: Tomás José González-Lopez, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Carlos Grande, MD          Principal Investigator: Carlos Grande, MD          Hospital Universitario Ramon y Cajal Recruiting Madrid, Spain Contact: Javier Lopez Jimenez, MD          Principal Investigator: Javier Lopez Jimenez, MD          MD Anderson Cancer Center Recruiting Madrid, Spain Contact: Adolfo de la Fuente, MD          Hospital Universitario Clinico de Salamanca Recruiting Salamanca, Spain Contact: Alejandro Martín, MD          Principal Investigator: Alejandro Martín, MD          Hospital Universitario Virgen del Rocio Recruiting Sevilla, Spain Contact: Fátima de la Cruz, MD          Principal Investigator: Fátima de la Cruz, MD          Hospital Clínico de Valencia Recruiting Valencia, Spain Contact: María José Terol, MD          Principal Investigator: María José Terol, MD Less <<
NCT02403271 Non-Small Cell Lung Cancer ... More >> Breast Cancer Pancreatic Cancer Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, Arizona Scottsdale, Arizona, United States United States, California La Jolla, California, United States Los Angeles, California, United States, 90025 Los Angeles, California, United States, 90048 Palo Alto, California, United States San Francisco, California, United States United States, Florida Gainesville, Florida, United States Orlando, Florida, United States United States, Illinois Chicago, Illinois, United States Peoria, Illinois, United States United States, New Jersey Hackensack, New Jersey, United States United States, North Carolina Durham, North Carolina, United States United States, Tennessee Memphis, Tennessee, United States Nashville, Tennessee, United States United States, Texas Houston, Texas, United States San Antonio, Texas, United States Less <<
NCT02959944 Chronic Graft Versus Host Dise... More >>ase Less << Phase 3 Recruiting March 2020 -
NCT02272686 Lymphoma PHASE2 TERMINATED 2017-12-22 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02272686 Lymphoma PHASE2 TERMINATED 2017-12-22 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02451111 Follicular Lymphoma Phase 2 Recruiting December 2029 Denmark ... More >> Aalborg Universitetshospital Recruiting Aalborg, Denmark, 9000 Contact: Paw Jensen, MD    +45 97663860    paje@rn.dk    Principal Investigator: Paw Jensen, MD          Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Ida Blok Sillesen, MD    +45 7846 5214    idasille@rm.dk    Principal Investigator: Ida Blok Sillesen, MD          Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Michael Pedersen, MD    +45 3545 8483    michael.pedersen.08@regionh.dk    Principal Investigator: Michael Pedersen, MD          Odense Universitetshospital Recruiting Odense C, Denmark, 5000 Contact: Lars Munksgaard, MD    Phone: +45 21 65 64 20    lars.munksgaard@rsyd.dk    Principal Investigator: Lars Munksgaard, MD          Norway Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Anne Turid Bjørnevik, MD    +47 454 625 98    anne.turid.bjornevik@helse-bergen.no    Principal Investigator: Anne Turid Bjørnevik, MD          Oslo University Hospital Recruiting Oslo, Norway, 424 Contact: Bjorn Ostenstad, MD    +47 (92) 218 077    UXBJOS@ous-hf.no    Principal Investigator: Bjorn Ostenstad, MD          Stavanger University Hospital Recruiting Stavanger, Norway, 4011 Contact: Peter Meyer, MD    +47 (51) 51 85 42    peter.albert.meyer@sus.no    Principal Investigator: Peter Meyer, MD          Universitetssykehuset i Nord-Norge Not yet recruiting Tromsø, Norway, 9038 Contact: Martin Maisenholder, MD       martin.maisenholder@unn.no    Principal Investigator: Martin Maisenholder, MD          Sweden Sunderby Hospital Recruiting Luleå, Sweden, 971 80 Contact: Lena Brandefors, MD    +46 (920) 28 00 41    lena.brandefors@nll.se    Principal Investigator: Lena Brandefors, MD          Skanes Universitetssjukhus Recruiting Lund, Sweden, 221 85 Contact: Ola Lindén, MD    +46 (46) 177 586    ola.linden@med.lu.se    Principal Investigator: Ola Lindén, MD          Karolinska University Hospital Recruiting Solna, Sweden, 17165 Contact: Björn Wahlin, MD    +46 73 382 11 65    bjorn.wahlin@gmail.com    Principal Investigator: Björn Wahlin, MD          Karolinska University Hospital Recruiting Stockholm, Sweden, 141 86 Contact: Björn Wahlin, MD    +46 73 382 11 65    bjorn.wahlin@karolinska.se    Principal Investigator: Björn Wahlin, MD          University Hospital of Umeå Recruiting Umeå, Sweden, 901 85 Contact: Ann-Sofie Johansson, MD    +46 (90) 785 28 59    annsofie.johansson@vll.se    Principal Investigator: Ann-Sofie Johansson, MD          Örebro University Hospital Recruiting Örebro, Sweden, 701 85 Contact: David Lofgren, MD       david.lofgren@regionorebrolan.se    Principal Investigator: David Lofgren, MD          Switzerland Hirslanden Klinik Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Klaus Peter Schalk, MD    +41 62 836 78 30    klaus.schalk@hirslanden.ch    Principal Investigator: Klaus Peter Schalk, MD          Kantonspital Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Mario Bargetzi, Prof    +41 62 838 60 53    mario.bargetzi@ksa.ch    Principal Investigator: Mario Bargetzi, Prof          Zuger Kantonsspital Recruiting Baar, Switzerland, 6340 Contact: Donat Dürr, MD    +41 41 399 40 67    donat.duerr@zgks.ch    Principal Investigator: Donat Dürr, MD          Kantonsspital Baden Recruiting Baden, Switzerland, CH-5404 Contact: Clemens B. Caspar, MD    41-56-486-2762    clemens.caspar@ksb.ch    Principal Investigator: Clemens Caspar, MD          St. Claraspital AG Recruiting Basel, Switzerland, CH-4016 Contact: Monika Ebnöther, MD    +41 61 685 83 69    monika.ebnoether@claraspital.ch    Principal Investigator: Monika Ebnöther, MD          Universitaetsspital Basel Recruiting Basel, Switzerland, CH-4031 Contact: Fatime Krasniqi, MD    +41 61 265 5059    KrasniqiF@uhbs.ch    Principal Investigator: Fatime Krasniqi, MD          Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Emanuele Zucca, MD    41-91-811-6772    ielsg@ticino.com    Principal Investigator: Emanuele Zucca, MD          Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD    +41 31 632 19 92    urban.novak@insel.ch    Principal Investigator: Urban Novak, MD          Spitalzentrum Oberwallis - Brig Recruiting Brig, Switzerland, 3900 Contact: Reinhard Zenhäusern, MD    +41 27 922 33 33    reinhard.zenhaeusern@hopitalvs.ch    Principal Investigator: Reinhard Zenhäusern, MD          Kantonsspital Bruderholz Recruiting Bruderholz, Switzerland, CH-4101 Contact: Lorenz M. Jost, MD    41-61-436-3636    lorenz.jost@ksbh.ch    Principal Investigator: Lorenz M. Jost, MD          Hopitaux Universitaires de Geneve Recruiting Genève 14, Switzerland, 1211 Contact: Eugenio Fernandez, MD    +41 22 372 29 01    Eugenio.Fernandez@hcuge.ch    Principal Investigator: Eugenio Fernandez, MD          Centre de Chimiothérapie Anti-Cancéreuse SA (CCAC) Recruiting Lausanne, Switzerland, 1004 Contact: Pierre Bohanes, MD    +41 21 646 79 94    p.bohanes@bluewin.ch    Principal Investigator: Pierre Bohanes, MD          Kantonsspital Baselland Recruiting Liestal, Switzerland, 4410 Contact: Michèle Voegeli, MD    +41 61 925 27 10    michele.voegeli@ksbl.ch    Principal Investigator: Michèle Voegeli, MD          Kantonsspital Luzern Recruiting Luzerne, Switzerland, CH-6000 Contact: Thilo Zander, MD    +41 41 205 11 11    thilo.zander@luks.ch    Principal Investigator: Thilo Zander, MD          Spital Thurgau (Kantonsspital Münserlingen und Frauenfeld) Recruiting Münsterlingen, Switzerland, 8596 Contact: Christian Taverna, MD    +41 71 686 22 02    christian.taverna@stgag.ch    Principal Investigator: Christian Taverna, MD          Kantonsspital Olten Recruiting Olten, Switzerland, CH-4600 Contact: Walter Mingrone, MD    41-62-311-4241    wmingrone_ol@spital.ktso.ch    Principal Investigator: Walter Mingrone, MD          Hôpital du Valais - CHCVR Recruiting Sion, Switzerland, 1951 Contact: Grégoire Berthod, MD    +41 27 603 87 71    gregoire.berthod@hopitalvs.ch    Principal Investigator: Grégoire Berthod, MD          Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Felicitas Hitz, MD    +41 71 494 11 11    felicitas.hitz@kssg.ch    Principal Investigator: Felicitas Hitz, MD          Spital STS AG Recruiting Thun, Switzerland, CH-3600 Contact: Daniel Rauch, MD    +41 33 226 26 45    daniel.rauch@spitalstsag.ch    Principal Investigator: Daniel Rauch, MD          Kantonsspital Winterthur Recruiting Winterthur, Switzerland, 8401 Contact: Natalie Fischer, MD    +41 052 266 40 87    natalie.fischer@ksw.ch    Principal Investigator: Natalie Fischer, MD          Stadtspital Triemli Recruiting Zürich, Switzerland, 8063 Contact: Adrian Schmidt, MD    +41 44 466 11 11    adrian.schmidt@triemli.zuerich.ch    Principal Investigator: Adrian Schmidt, MD          UniversitätsSpital Zürich Recruiting Zürich, Switzerland, 8091 Contact: Thorsten Zenz, Prof    +41 44 255 94 69    thorsten.zenz@usz.ch    Principal Investigator: Thorsten Zenz, Prof          Onkozentrum Hirslanden Recruiting Zürich, Switzerland, CH-8032 Contact: Christoph Renner, Prof    +41 44 387 37 80    crenner@onkozentrum.ch    Principal Investigator: Christoph Renner, Prof Less <<
NCT02315768 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Recruiting November 2021 United States, California ... More >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Less <<
NCT03514017 Chronic Lymphocytic Leukemia Phase 2 Not yet recruiting December 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Elyse Turba    813-745-1706    elyse.turba@moffitt.org    Contact: Julio Chavez, M.D.    813-745-2069    julio.chavez@moffitt.org Less <<
NCT03149315 Food Allergy|Anaphylaxis Food PHASE2 COMPLETED 2018-11-14 Ann & Robert H. Lurie Children... More >>s Hospital of Chicago, Chicago, Illinois, 60611, United States Less <<
NCT03422393 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 1 Recruiting August 2028 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Less <<
NCT03332498 Colon Cancer ... More >>Colorectal Cancer Colorectal Carcinoma Colon Disease Less << Phase 1 Phase 2 Recruiting February 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Maria Martinez Jimenez    813-745-1946    maria.martinez@moffitt.org    Contact: Richard Kim, M.D.    813-745-1277    richard.kim@moffitt.org    Principal Investigator: Richard Kim, M.D. Less <<
NCT02351037 - Terminated(Study data do not s... More >>upport development in AML.) Less << - -
NCT02351037 Acute Myeloid Leukemia (AML) Phase 2 Terminated(Study data do not s... More >>upport development in AML.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 UC Davis Medical Center Sacramento, California, United States, 95817 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, New York Montefiore Einstein Center for Cancer Research Bronx, New York, United States, 10461 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02301156 Chronic Lymphocytic Leukemia Phase 3 Active, not recruiting November 2019 -
NCT02420912 Leukemia Chro... More >>nic Lymphocytic Leukemia Less << Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02604511 Waldenstrom's Macroglobulinemi... More >>a Less << PHASE2 COMPLETED 2022-11-01 Massacusetts General Hospital,... More >> Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT02269085 Lymphoma Phase 1 Phase 2 Terminated(slow accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03399513 Diffuse Large B Cell Lymphoma Phase 2 Recruiting February 2022 Germany ... More >> Universitätsklinikum Münster Recruiting Münster, Nordrhein-Westfalen, Germany, 48149 Less <<
NCT02356458 Mantle Cell Lymphoma Phase 1 Phase 2 Recruiting March 2021 Germany ... More >> Universitätsmedizin Mainz Recruiting Mainz, Germany, 55131 Contact: Georg Hess, Prof    +49 6131 17 50 40    georg.hess@unimedizin-mainz.de    Principal Investigator: Georg Hess, Prof          Klinikum der Universität München Recruiting München, Germany, 81377 Contact: Martin Dreyling, Prof    +49 (089) 4400 72202    martin.dreyling@med.uni-muenchen.de    Principal Investigator: Martin Dreyling, Prof          Universitätsmedizin Rostock Recruiting Rostock, Germany, 18057 Contact: Sebastian Böttcher, MD    +49 381 494 7405    sebastian.boettcher@med.uni-rostock.de    Principal Investigator: Sebastian Böttcher, MD          Italy Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy, 15100 Contact: Marco Ladetto, MD    +39 131206 262    marco.ladetto@ospedale.al.it    Principal Investigator: Marco Ladetto, MD          European Institute of Oncology Recruiting Milano, Italy, 20141 Contact: Corrado Tarella, Prof    +39 02-57489.538    corrado.tarella@unito.it    Principal Investigator: Corrado Tarella, Prof          Università di Torino Recruiting Torino, Italy, 10126 Contact: Simone Ferrero, MD    +39 011 633 4220    simone.ferrero@unito.it    Principal Investigator: Simone Ferrero, MD          Switzerland Kantonsspital Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Mario Bargetzi, Prof    41-62-838-6053    mario.bargetzi@ksa.ch    Principal Investigator: Mario Bargetzi, Prof          Kantonsspital Baden Recruiting Baden, Switzerland, 5404 Contact: Clemens Caspar, MD    +41 56 486 27 62    clemens.caspar@ksb.ch    Principal Investigator: Clemens Caspar, MD          Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD    +41 31 632 41 14    urban.novak@insel.ch    Principal Investigator: Urban Novak, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ulrich Mey, MD    +41 81 256 71 70    ulrich.mey@ksgr.ch    Principal Investigator: Ulrich Mey, MD          Hopitaux Universitaires de Geneve Recruiting Genève 14, Switzerland, 1211 Contact: Noémie Lang, MD    +41 79 55 32 398    noemie.lang@hcuge.ch    Principal Investigator: Noémie Lang, MD          Centre Pluridisciplinaire d`Oncologie CHUV Recruiting Lausanne, Switzerland, 1011 Contact: Anne Cairoli, MD    +41 (0)21 314 41 82    anne.cairoli@chuv.ch    Principal Investigator: Anne Cairoli, MD          Kantonsspital Baselland Recruiting Liestal, Switzerland, 4410 Contact: Michèle Voegeli, MD    +41 61 925 27 10    michele.voegeli@ksbl.ch    Principal Investigator: Michèle Voegeli, MD          Istituto Oncologico della Svizzera Italiana Recruiting Lugano, Switzerland, CH-6900 Contact: Emanuele Zucca, Prof    +41 91 811 91 47    emanuele.zucca@eoc.ch    Principal Investigator: Emanuele Zucca, Prof          Kantonsspital Luzern Recruiting Luzerne, Switzerland, CH-6000 Contact: Thilo Zander, MD    +41 41 205 11 11    thilo.zander@luks.ch    Principal Investigator: Thilo Zander, MD          Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Martin Fehr, MD    +41 71 494 11 11    martin.fehr@kssg.ch    Principal Investigator: martin fehr, MD          Klinik Hirslanden Recruiting Zurich, Switzerland, CH-8032 Contact: Christoph Renner, Prof    +41 43 344 33 44    christoph.renner@hirslanden.ch    Principal Investigator: Christoph Hirslanden, Prof          Onkozentrum - Klinik Im Park Recruiting Zürich, Switzerland, 8038 Contact: Christoph Renner, Prof    +41 43 344 33 33    christoph.renner@hirslanden.ch    Principal Investigator: Christoph Renner, Prof          UniversitätsSpital Zürich Recruiting Zürich, Switzerland, 8091 Contact: Thorsten Zenz, Prof    +41 44 255 94 96    thorsten.zenz@usz.ch    Principal Investigator: Thorsten Zenz, Prof Less <<
NCT03476655 Leukemia, Lymphocytic, Chronic... More >>, B-Cell|Lymphoma, Mantle-Cell Less << COMPLETED 2019-05-31 Apollo Hospitals International... More >> Limited, Ahmedabad, 382428, India|Healthcare Global (HCG) Hospital, Bangalore, 560013, India|Fortis Memorial Research Institute, Gurgaon, 122002, India|Basavatarakam Indo-American Hospital, Hyderabad, 500034, India|Bhagwan Mahaveer Hospital & Research Centre, Jaipur, 302017, India|Tata Medical Center, Kolkata, 700156, India|All India Institute of Medical Sciences, New Delhi, 110029, India|Yashoda Hematology Clinic, Pune, 411002, India Less <<
NCT02950038 Lung Cancer, Nonsmall Cell, St... More >>age I Less << Phase 2 Withdrawn - -
NCT02558816 Mantle Cell Lymphoma Phase 1 Phase 2 Recruiting October 2023 France ... More >> CHU Angers Not yet recruiting Angers, France, 49033 Contact: Marie-Pierre MOLES-MOREAU    +33 2 41 35 45 82    mpmoles@chu-angers.fr    CHU de Dijon Not yet recruiting Dijon, France, 21000 Contact: René-Olivier Casasnovas, Pr       olivier.casasnovas@chu-dijon.fr    Hôpital Claude Huriez - CHRU de Lille Recruiting Lille, France, 59037 Contact: Franck Morschhauser, Pr    00 33 3 20 44 60 68    franck.morschhauser@chru-lille.fr    Hôpital Saint Eloi Recruiting Montpellier, France, 34295 Contact: Guillaume Cartron, Pr       g-cartron@chu-montpellier.fr    CHU de Nantes Recruiting Nantes, France, 44093 Contact: Steven LE GOUILL, Pr          Hôpital du Haut Lévêque Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH, Pr       krimo.bouabdallah@chu-bordeaux.fr    CHU Rennes Not yet recruiting Rennes, France, 35033 Contact: LAMY DE LA CHAPELLE Thierry    + 33 2 99 28 42 91    thierry.lamy@chu-rennes.fr    United Kingdom Derriford Hospital _ Plymouth Hospitals NHS Trust Not yet recruiting Plymouth, Devon, United Kingdom, PL6 8DH Contact: Simon RULE, Pr       simon.rule@nhs.net    University of Southampton Not yet recruiting Southampton, United Kingdom, SO16 6YD Contact: Andrew DAVIES, Dr       a.davies@southampton.ac.uk Less <<
NCT02638116 Healthy Phase 1 Completed - Belgium ... More >> Antwerpen, Belgium Less <<
NCT03232307 Hematopoietic/Lymphoid Cancer ... More >> Mantle Cell Lymphoma Less << Phase 2 Not yet recruiting January 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       miwang@mdanderson.org Less <<
NCT02827617 Chronic Lymphocytic Leukemia ACTIVE_NOT_RECRUITING 2024-12-31 Onco Ematologia Clinico Sperim... More >>entale, I.R.C.C.S. Centro di Riferimento Oncologico, Aviano, 33081, Italy|Ospedale San Raffaele, Milano, 20132, Italy|Dipartimento di Ematologia, Niguarda Cancer Center, Ospedale Niguarda, Milano, 20133, Italy|Department of Medical and Surgical Sciences, section of Hematology, Modena, 41124, Italy|Divisione di Ematologia, Universita' del Piemonte Orientale, Novara, 28100, Italy|Institute of Hematology, Catholic University S. Cuore, Roma, 00168, Italy|Department of Haematology, Tor Vergata Hospital, Rome, 00133, Italy|Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Udine, 33100, Italy|Ematologia, Ospedale di Circolo e Fondazione Macchi, Varese, 21100, Italy|Division of Hematology, Department of Internal Medicine, Basel University Hospital, Basel, 4031, Switzerland|Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland|Clinica Luganese Moncucco, Lugano, 6903, Switzerland|Hematology, Luzern Kantonsspital, Luzern, 6000, Switzerland Less <<
NCT02575300 Carcinoid Tumors|Pancreatic NE... More >>T Less << PHASE2 COMPLETED 2019-11-04 H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612, United States Less <<
NCT03703167 Primary Central Nervous System... More >> Lymphoma (PCNSL) Secondary Central Nervous System Lymphoma (SCNSL) Less << Phase 1 Not yet recruiting November 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Christian Grommes, MD    212-639-4058       Contact: Ingo Mellinghoff, MD    646-888-2766 Less <<
NCT02556892 Lymphocytic Leukemia PHASE1 COMPLETED 2018-08-20 Fukuoka-city, Japan|Hiroshima,... More >> Japan|Isehara, Japan|Kobe-city,, Japan|Koto-ku, Japan|Osaka, Japan|Sapporo, Japan|Tachikawa, Japan Less <<
NCT03454165 Chronic Lymphocytic Leukemia Phase 1 Recruiting December 2020 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Lionel D Lewis, MD    603-650-7811       Contact: Bridget M Labrie, MBA    603-650-6227    bridget.m.labrie@hitchcock.org Less <<
NCT02309580 T-cell Lymphoma|Relapsed and R... More >>efractory T-cell Lymphoma Less << PHASE1 COMPLETED 2023-05-08 Memorial Sloan Kettering Cance... More >>r Center, New York, New York, 10065, United States|Ohio State University, Columbus, Ohio, 43210, United States Less <<
NCT03734198 Relapsed or Refractory Chronic... More >> Lymphocytic Leukemia Less << Phase 2 Not yet recruiting June 2027 France ... More >> CH Annecy Genevois - Hématologie A3 Not yet recruiting Annecy, France, 74374 Contact: Stéphane TARDY, Dr    04 50 63 66 08    stardy@ch-annecygenevois.fr    CHU Jean Minjoz - Hématologie Not yet recruiting Besançon, France, 25000 Contact: Annie BRION, Dr    03 81 66 82 32 ext 33    abrion@chu-besancon.fr    Hôpital Avicenne - Centre de Recherche Clinique Not yet recruiting Bobigny, France, 93009 Contact: Vincent LEVY, Pr    01 48 95 56 41    vincent.levy@avc.aphp.fr    CHU Caen - IHBN - Hématologie Clinique Not yet recruiting Caen, France, 14033 Contact: Jean-Pierre VILQUE, Dr    02 31 27 21 34    vilque-jp@chu-caen.fr    CHU Estaing - Hématologie Clinique Adulte Clermont-Ferrand, France, 63000 CHU Grenoble - Hématologie Not yet recruiting Grenoble, France, 388043 Contact: Lysiane MOLINA, Dr    04 76 76 57 55    LMolina@chu-grenoble.fr    CHD Vendée Not yet recruiting La Roche-sur-Yon, France, 85925 Contact: Bruno VILLEMAGNE, Dr    02 51 44 61 73    bruno.villemagne@chd-vendee.fr    Centre Hospitalier du Mans Not yet recruiting Le Mans, France, 72000 Contact: Kamel LARIBI, Dr    02 43 43 43 43    klaribi@ch-lemans.fr    Centre Léon Bérard - Hématologie Not yet recruiting Lyon, France, 69373 Contact: Anne-Sophie MICHALLET, Dr    04 78 78 26 41    anne-sophie.michallet@lyon.unicancer.fr    CHLS - Lyon Pierre Bénite - Service Hématologie Not yet recruiting Lyon, France, 69495 Contact: Emmanuelle FERRAND, Dr    04 78 86 45 21    emmanuelle.ferrant2@chu-lyon.fr    Institut Paoli-Calmettes - Hématologie Clinique Not yet recruiting Marseille, France, 13273 Contact: Thérèse AURRAN, Dr    04 91 22 38 68    aurrant@ipc.unicancer.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Emanuelle TCHERNONOG, Dr    04 67 33 24 17    e-tchernonog@chu-montpellier.fr    CHU Hôtel Dieu - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Béatrice MAHE, Dr    02 40 08 32 71    beatrice.mahe@chu-nantes.fr    Hôpital Pitié Salpétrière - Hématologie Not yet recruiting Paris, France, 75651 Contact: Véronique LEBLOND, Pr    01 42 16 28 24    veronique.leblond@aphp.fr    CHU Bordeaux - Hôpital Haut-Lévèque - CFM Maladies du sang Not yet recruiting Pessac, France, 33604 Contact: Marie-Sarah DILHUYDY, Dr    05 57 65 65 11    marie-sarah.dilhuydy@chu-bordeaux.fr    Hôpital de la Milétrie - Hématologie et Thérapie Cellulaire Not yet recruiting Poitiers, France, 86021 Contact: Cécile TOMOWIAK, Dr    05 49 44 43 07    cecile.tomowiak@chu-poitiers.fr    Hôpital Robert Debré - Hématologie Clinique Not yet recruiting Reims, France, 51092 Contact: Alain DELMER, Pr    03 26 78 36 44    adelmer@chu-reims.fr    CHU Pontchaillou - Hématologie Clinique BMT-HC Not yet recruiting Rennes, France, 35033 Contact: Sophie DE GUIBERT, Pr    02 99 28 42 91    sophie.de.guibert@chu-rennes.fr    Centre Henri Becquerel - Service Hématologie Clinique Rouen, France, 76038 Hôpital Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Luc-Matthieu FORNECKER, Dr    03 88 12 76 70    luc-matthieu.fornecker@chru-strasbourg.fr    IUCT ONCOPOLE - Hématologie Not yet recruiting Toulouse, France, 31059 Contact: Loïc YSEBAERT, Dr    05 31 15 63 51    ysebaert.loic@iuct-oncopole.fr    Hôpital Bretonneau - Hématologie et Thérapie Cellulaire Not yet recruiting Tours, France, 37044 Contact: Caroline DARTIGEAS, Dr    02 47 47 37 12    c.dartigeas@chu-tours.fr    Hôpitaux de Brabois - Hématologie Adulte Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Pierre FEUGIER, Pr    03 83 15 32 82    p.feugier@chru-nancy.fr Less <<
NCT01674322 Healthy Participants PHASE1 COMPLETED 2025-09-12 Merksem, Belgium
NCT02169180 Lymphoma, Mantle-cell PHASE2 COMPLETED 2025-12-16 Fukuoka, Japan|Isehara, Japan|... More >>Kobe, Japan|Kyoto, Japan|Nagoya, Japan|Osaka, Japan|Sendai, Japan|Tokyo, Japan Less <<
NCT02321540 Lung Cancer PHASE1|PHASE2 COMPLETED 2021-09-16 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT03474679 Graft vs Host Disease PHASE3 COMPLETED 2021-11-29 Anjo Kosei Hospital, Anjo-shi,... More >> 446-8602, Japan|Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, 113 8677, Japan|Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, 730-8619, Japan|Tokai University Hospital, Isehara, 259-1193, Japan|Osaka Women's and Children's Hospital, Izumi, 594-1101, Japan|Kobe City Medical Center General Hospital, Kobe City, 650 0047, Japan|National Hospital Organization Kumamoto Medical Center, Kumamoto-shi, 860-0008, Japan|Kurashiki Central Hospital, Kurashiki, 710-8602, Japan|Gunmaken Saiseikai Maebashi Hospital, Maebashi, 371-0821, Japan|Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, 453-8511, Japan|The Hospital of Hyogo College of Medicine, Nishinomiya, 663-8501, Japan|Okayama University Hospital, Okayama, 700 8558, Japan|Osaka City University Hospital, Osaka, 545 8586, Japan|Hokkaido University Hospital, Sapporo-shi, 060-8648, Japan|National Center for Child Health and Development, Setagaya Ku, 157 8535, Japan Less <<
NCT03708003 Relapsed/Refractory Chronic Ly... More >>mphocytic Leukemia Chronic Lymphocytic Leukemia Leukemia Less << Phase 2 Not yet recruiting December 2028 Switzerland ... More >> Kantonsspital Aarau Not yet recruiting Aarau, Switzerland, CH-5001 Contact: Nathan Cantoni, MD    +41 62 838 60 50    nathan.cantoni@ksa.ch    Principal Investigator: Nathan Cantoni, MD          Universitätsspital Basel Not yet recruiting Basel, Switzerland, 4031 Contact: Dominik Heim, MD    +41 61 328 63 11    dominik.heim@usb.ch    Principal Investigator: Dominik Heim, MD          IOSI - Ospedale San Giovanni Not yet recruiting Bellinzona, Switzerland, 6501 Contact: Davide Rossi, MD    +41 91 811 85 40    davide.rossi@eoc.ch    Principal Investigator: Davide Rossi, MD          Inselspital Not yet recruiting Bern, Switzerland, 3010 Contact: Martin Andres, MD    +41 31 632 90 23    martin.andres@insel.ch    Principal Investigator: Martin Andres, MD          Kantonsspital Graubünden Not yet recruiting Chur, Switzerland, 7000 Contact: Dirk Kienle, MD    +41 81 256 71 73    dirk.kienle@ksgr.ch    Principal Investigator: Dirk Kienle, MD          Kantonsspital Liestal Not yet recruiting Liestal, Switzerland, CH-4410 Contact: Geneviève Favre, MD    +41 61 925 27 11    genevieve.favre@ksbl.ch    Principal Investigator: Geneviève Favre, MD          Luzerner Kantonsspital Not yet recruiting Luzern, Switzerland, 6000 Contact: Michael Gregor, MD    +41 41 205 53 13    michael.gregor@luks.ch    Principal Investigator: Michael Gregor, MD          Kantonsspital Münsterlingen Not yet recruiting Münsterlingen, Switzerland, 8596 Contact: Rudolf Benz, MD    +41 71 686 11 11    rudolf.benz@stgag.ch    Principal Investigator: Rudolf Benz, MD          Spital STS AG Thun Not yet recruiting Thun, Switzerland, 3600 Contact: Max Solenthaler, MD    +41 58 636 26 45    max.solenthaler@spitalstsag.ch    Principal Investigator: Max Solenthaler, MD          Kantonsspital Winterthur Not yet recruiting Winterthur, Switzerland, 8401 Contact: Jeroen Goede, MD    +41 52 266 36 97    jeroen.goede@ksw.ch    Principal Investigator: Jeroen Goede, MD          Universitätsspital Zürich Not yet recruiting Zürich, Switzerland, 8091 Contact: Anouk Widmer, MD    +41 44 255 12 94    anouk.widmer@usz.ch    Principal Investigator: Anouk Widmer, MD Less <<
NCT02315326 Refractory/Recurrent Primary C... More >>entral Nervous System Lymphoma (PCNSL) Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) Less << Phase 1 Phase 2 Recruiting December 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Christian Grommes, MD    212-639-4058       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Christian Grommes, MD    212-639-4058       Contact: Ingo Mellinghoff, MD    646-888-3036 Less <<
NCT03689894 Chronic Graft-versus-host-dise... More >>ase Less << Phase 1 Not yet recruiting December 2024 -
NCT03684694 Diffuse Large B-Cell Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 1 Not yet recruiting September 2022 -
NCT02013128 Chronic Lymphocytic Leukemia ... More >> Mantle Cell Lymphoma Less << Phase 1 Phase 2 Active, not recruiting November 2018 United States, Alabama ... More >> TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States, 35805 United States, Arizona TG Therapeutics Investigational Trial Site Tucson, Arizona, United States, 85710 United States, California TG Therapeutics Investigational Trial Site Santa Barbara, California, United States, 93105 United States, Colorado TG Therapeutics Investigational Trial Site Boulder, Colorado, United States, 80303 United States, Illinois TG Therapeutics Investigational Trial Site Niles, Illinois, United States, 60714 TG Therapeutics Investigational Trial Site Urbana, Illinois, United States, 61801 United States, Maryland TG Therapeutics Investigational Trial Site Bethesda, Maryland, United States, 20817 United States, New Jersey TG Therapeutics Investigational Trial Site Morristown, New Jersey, United States, 07962 United States, Oregon TG Therapeutics Investigational Trial Site Portland, Oregon, United States, 97213 TG Therapeutics Investigational Trial Site Springfield, Oregon, United States, 97477 United States, South Carolina TG Therapeutics Investigational Trial Site Greenville, South Carolina, United States, 29615 United States, Tennessee TG Therapeutics Investigational Trial Site Memphis, Tennessee, United States, 38120 United States, Texas TG Therapeutics Investigational Trial Site Austin, Texas, United States, 78705 TG Therapeutics Investigational Trial Site Dallas, Texas, United States, 75230 TG Therapeutics Investigational Trial Site Tyler, Texas, United States, 75702 United States, Virginia TG Therapeutics Investigational Trial Site Blacksburg, Virginia, United States, 24060 TG Therapeutics Investigational Trial Site Fairfax, Virginia, United States, 22031 United States, Washington TG Therapeutics Investigational Trial Site Vancouver, Washington, United States, 98684 Less <<
NCT02914327 Cancer Phase 1 Withdrawn(Lack of enrollment) - United States, Ohio ... More >> Wexner Medical Center, Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02943473 High Risk Smoldering Multiple ... More >>Myeloma Less << PHASE2 TERMINATED 2019-09-10 Icahn School of Medicine at Mo... More >>unt Sinai, New York, New York, 10029, United States Less <<
NCT03229200 Lymphoma, B-Cell|Lymphoma, Non... More >>-Hodgkin|Leukemia, B-cell|Graft Vs Host Disease|Solid Tumor Less << PHASE4 ENROLLING_BY_INVITATION 2027-05-10 Providence Health System - Sou... More >>thern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center, Burbank, California, 91505, United States|City Of Hope National Medical Center, Duarte, California, 91010, United States|UCSD Moores Cancer Center, La Jolla, California, 92093-0698, United States|University of California Los Angeles (UCLA), Los Angeles, California, 90095, United States|Stanford University, Stanford, California, 94305, United States|Emory University, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Chicago, Chicago, Illinois, 60637, United States|Norton Medical Plaza II, 3991 Dutchmans Lane, Louisville, Kentucky, 40207, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|TRIO - Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169-3321, United States|John Theurer Cancer Center, Hackensack UMC, Hackensack, New Jersey, 07601, United States|San Juan Oncology Associates, Farmington, New Mexico, 87401, United States|Northwell Health, New Hyde Park, New York, 11042, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065-6007, United States|Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Southeastern Medical Oncology Center, Goldsboro, North Carolina, 27534-9479, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, 45267, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Mid Ohio Oncology/Hematology Inc., DBA The Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|Vanderbilt Ingram Cancer Center, Nashville, Tennessee, 37232, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|M.D. Anderson Cancer Centre, Houston, Texas, 77030, United States|US Oncology Research, LLC, The Woodlands, Texas, 77380, United States|University of Vermont Medical Center, Burlington, Vermont, 05405, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Northwest Cancer Specialists, Compass Oncology, Vancouver, Washington, 09868, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, 98801, United States|Yakima Valley Memorial Hospital, Yakima, Washington, 98902, United States|St. George Hospital, Kogarah, New South Wales, 2217, Australia|Concord Repatriation General Hospital - Haematology Clinical Trials, Sydney, New South Wales, 2139, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Flinders Medical Centre, Bedford Park, South Australia, 5067, Australia|Ballarat Health Services, Ballarat, Victoria, 3350, Australia|Eastern Health, Box Hill, Victoria, 3128, Australia|Monash Health-Monash Medical Centre, Clayton, Victoria, 3168, Australia|St Vincent Hospital, Fitzroy, Victoria, 3065, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia|QEII Health Science Centre, Halifax, Nova Scotia, B3H 2Y9, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G2M9, Canada|McGill University Health Center, Montréal, Quebec, H4A3J1, Canada|University Hospital Hradec Kralove, Hradec Králové, Kralovehradecky Kraj, 50005, Czechia|Hematology and Oncology Masaryk University Hospital Brno, Brno, 62500, Czechia|University Hospital Pilsen, Pilsen, 30460, Czechia|Charles University Hospital, Prague, Prague, 12808, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha 10, 100 34, Czechia|CHU Hotel Dieu, Nantes, Loire Atlantique, 44000, France|Centre Henri Becquerel, Rouen Cedex, 76038, France|Centre Hospitalier Saint Brieuc, Saint-Brieuc, 22000, France|Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases, Dept of Hematology and Stem Cell, Budapest, 1097, Hungary|Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Ospedale San Raffaele IRCCS, Milano, 20132, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy|Azienda Ospedaliera di Padova, Padova, 35128, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, 27100, Italy|Azienda Ospedaliera Citt? della Salute e della Scienza di Torino, Torino, 10126, Italy|Azienda Sanitaria Universitaria Integrata Udine, Udine, 33100, Italy|Kyungpook National University Hospital (KNUH), Daegu, 41944, Korea, Republic of|Middlemore Hospital, Papatoetoe, Auckland, 2025, New Zealand|North Shore Hospital, Auckland, 0622, New Zealand|Szpital Specjalistyczny w Brzozowie, Oddzia? Hematologii Onkologicznej z Klinicznym Oddzia?em Przeszczepiania Szpiku, Brzozów, Podkarpackie, 36-200, Poland|Klinika Hematologii i Transplantologii, Gdańsk, Pomorskie, 80-211, Poland|SPZOZ ZSM w Chorzowie, Chorzów, Silesia, 41-500, Poland|Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika, ?ód?, 93-510, Poland|Nizhniy Novgorod Regional Clinical Hospital n.a. N.A. Semashko, Nizhniy Novgorod, Nizhegorodskaya, 603126, Russian Federation|SBI of Ryazan region "Regional Clinical Hospital", Ryazan', Ryazan Region, 390039, Russian Federation|Russian Scientific and Research Institute of Hematology and Transfusiology of Federal Medical Biological Agency, Saint Petersburg, 191024, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, 197341, Russian Federation|Yaroslavl Regional Clinical Hospital, Yaroslavl, 150062, Russian Federation|ICO - Hospital Germans Trias I Pujol, Badalona, Barcelona, 08916, Spain|Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, 28222, Spain|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital de Sanata Creus i Sant Pau, Barcelona, 08041, Spain|ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, 08908, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|University Hospital of Salamanca, Salamanca, 37007, Spain|Sunderby hospital, Lule?, Norrbotten, 97180, Sweden|S?dra ?lvsborg Hospital Bor?s, Bor?s, 50182, Sweden|Karolinska Universitetssjukhuset, Solna, Solna, 171 76, Sweden|China Medical University Hospital, Taichung, 40447, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Pamukkale University Medical Faculty, Denizli, Pamukkale, 20070, Turkey|Ankara Universitesi Tip Fakultesi Hastanesi, Ankara, 06100, Turkey|Gazi University, Ankara, 06500, Turkey|VKV American Hospital, Istanbul, 34365, Turkey|Dokuz Eylul University, ?zmir, 35340, Turkey|CNE CCOHTPC of Cherkasy Regional Council, Cherkasy, 18009, Ukraine|CNCE City Clinical Hospital 4 of Dnipro City Council, Dnipro, 49102, Ukraine|SI Institute of Blood Pathology and Transfusion Medicine of AMSU, Lviv, 79044, Ukraine|University Hospital of Wales, Cardiff, CF14 4XW, United Kingdom|Leeds Teaching Hospitals NHS, Leeds, LS9 7TF, United Kingdom|University College Hospitals NHS Foundation Trust, London, NW1 2PG, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom Less <<
NCT02884453 Gastrooesophageal Cancer Phase 2 Recruiting July 2019 United Kingdom ... More >> The Royal Marsden NHS Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Ye mong To    0208 661 3807    yemong.to@rmh.nhs.uk    Contact: Michael Davidson    020 8642 6011 ext 4374       Principal Investigator: Ian Chau          Sub-Investigator: Michael Davidson          Sub-Investigator: Irene Chong Less <<
NCT03129828 Diffuse Large B Cell Lymphoma Phase 1 Phase 2 Recruiting March 31, 2022 Germany ... More >> Charité - Universitätsmedizin Berlin, Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Clemens Schmitt, Prof. Dr.    +49-30-450 553 896    clemens.schmitt@charite.de    Contact: Sophy Denker, Dr.    +49-30-450 653 569    sophy.denker@charite.de    Principal Investigator: Clemens Schmitt, Prof. Dr. Less <<
NCT02973399 Cancer Phase 1 Active, not recruiting February 2019 United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Wexner Medical Center, Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03679624 Waldenstrom Macroglobulinemia ... More >> Waldenstrom's Disease Waldenstr?m; Hypergammaglobulinemia Waldenstrom's Macroglobulinemia Recurrent Waldenstrom's Macroglobulinemia of Lymph Nodes Waldenstrom's Macroglobulinaemia, Without Mention of Remission Waldenstrom's Macroglobulinemia Refractory Less << Phase 2 Not yet recruiting November 2023 United States, New York ... More >> Weill Cornell Medicine Not yet recruiting New York, New York, United States, 10065 Contact: Amelyn Rodriguez, R.N.    212-746-1362    amr2017@med.cornell.edu    Contact: Rita Vaccaro, R.N.    212-746-0702    rig9021@med.cornell.edu    Principal Investigator: John Allan, M.D. Less <<
NCT03282396 Mantle Cell Lymphoma PHASE2 ACTIVE_NOT_RECRUITING 2026-02-28 M D Anderson Cancer Center, Ho... More >>uston, Texas, 77030, United States Less <<
NCT02801578 Chronic Lymphocytic Leukemia PHASE2|PHASE3 COMPLETED 2019-01-28 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02757040 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 3 Unknown December 2018 -
NCT03720561 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << COMPLETED 2021-11-12 Ospedali Riuniti Di Ancona, An... More >>cona, 60126, Italy|U.O.C. Ematologia e Terapia Cellulare Ospedale C e G Mazzoni, Ascoli Piceno, 63100, Italy|U.O. Ematologia con Trapianto- AOU Policlinico di Bari, Bari, 70124, Italy|U.O. Ematologia Istituto Tumori Giovanni Paolo II, Bari, 70124, Italy|S.C. Ematologia e CTMO P.O. Businco A.O. Brotzu, Cagliari, 09121, Italy|AORN Sant'anna e San Sebastiano, Caserta, 81100, Italy|Div.Clinicizzata EmatologiaconTrapiantodi MidolloOsseo P.O.Rodoligo AOUPoliclinico-Vittorio Emanuele, Catania, 95124, Italy|S.O.C. Ematologia P.O. Ciaccio A.O. Pugliese-Ciaccio, Catanzaro, 88100, Italy|Azienda Ospedaliero Universitaria di Ferrara, Cona, 44124, Italy|S.C. Ematologia Azienda Ospedaliera S. Croce e Carle, Cuneo, 12100, Italy|Unità Funzionale di Ematologia Azienda ospedaliero-universitaria Careggi, Firenze, 50134, Italy|S.C. Ematologia A.O.U. Ospedali Riuniti, Foggia, 71100, Italy|Ematologia Ospedale San Martino, Genova, 16132, Italy|U.O.C. Ematologia Ospedale V. Fazzi, Lecce, 73100, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, 47014, Italy|U.O.C. Ematologia Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Programma di ricerca strategica sulla LLC Ospedale San Raffaele, Milano, 20132, Italy|Divisione ematologia Grande Ospedale Metropolitano Niguarda, Milano, 20133, Italy|Division of Hematology, Cardarelli Hospital, Napoli, 80131, Italy|U.O.C. Ematologia e Trapianti di midollo A.O.U. Federico II, Napoli, 80131, Italy|Ospedale San Francesco, Nuoro, 08100, Italy|U.O.C. Ematologia e Immunologia Clinica Azienda Ospedaliera Padova, Padova, 35128, Italy|U.O. Ematologia ed Oncologia Ospedale A. Tortora, Pagani, 84016, Italy|Ospedale 'Villa Sofia-Cervello, Palermo, 90146, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|S.C. Ematologia A.O.U. Santa Maria della Misericordia, Perugia, 06132, Italy|UOSD Centro diagnosi e terapia dei linfomi Ospedale Santo Spirito, Pescara, 65124, Italy|U.O.C. Ematologia Ospedale S. Maria delle Croci, Ravenna, 48121, Italy|Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, 42123, Italy|DH Oncoematologia Policlinico Tor Vergata, Roma, 00133, Italy|Università di Roma 'La Sapienza' - Ospedale Umberto 1°, Roma, 00161, Italy|Ematologia Fondazione Univ. Policlinico Gemelli Università Cattolica del Sacro Cuore, Roma, 00168, Italy|Azienda Ospedaliera Sant Andrea, Roma, 189, Italy|UO Oncologia ed Ematologia Istituto Clinico Humanitas, Rozzano, 20089, Italy|U.O.C. Ematologia e Trapianti Cellule Staminali Emopoietiche AOU S.Giovanni di Dio e Ruggi D'Aragona, Salerno, 84131, Italy|Ospedale 'Casa Sollievo della Sofferenza' - U.O. Ematologia-, San Giovanni Rotondo, 71013, Italy|Azienda Ospedaliera 'Santa Maria', Terni, Italy|S.C. Ematologia U A.O.U. Citta della Salute e della Scienza P.O.Molinette, Torino, 10126, Italy|U.O. Ematologia Ospedale San Bortolo, Vicenza, 36100, Italy Less <<
NCT03513562 Chronic Lymphocytic Leukemia ... More >> Ibrutinib Resistance Less << Phase 2 Not yet recruiting February 28, 2021 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Kerry A. Rogers, MD    614-366-9338    kerry.rogers@osumc.edu    Principal Investigator: Kerry A. Rogers, MD Less <<
NCT03535350 Glioblastoma Phase 1 Recruiting April 1, 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet S. Ahluwalia, MD, FACP    216-444-6145    ahluwam@ccf.org Less <<
NCT02955628 Diffuse Large B Cell Lymphoma ... More >> Diffuse Large B-Cell Lymphoma Recurrent Less << Phase 2 Recruiting August 2023 Singapore ... More >> National University Hospital Singapore Not yet recruiting Singapore City, Singapore, 119074 Contact: Michelle Poon, MD    6567795555    NUH_Enquiries@nuhs.edu.sg    National Cancer Centre Singapore Not yet recruiting Singapore City, Singapore, 169610 Contact: Tiffany Tang, MD    6564368000    Callcentre@nccs.com.sg    Raffles Hospital Singapore Not yet recruiting Singapore City, Singapore, 188770 Contact: Daryl Tan, MD    6563111111       Contact: Daryl.Tan.c.l@sgh.com.sg          Singapore General Hospital Recruiting Singapore, Singapore, 169608 Contact: Colin Phipps, MD    6562223322    Colin.phipps.diong@singhealth.com.sg Less <<
NCT02912754 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Phase 2 Not yet recruiting August 2019 Canada, Ontario ... More >> Sunnybrook Odette Cancer Center Not yet recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Geetha Geetha Yogendran, BSc    416-480-5000 ext 89565    geetha.yogendran@sunnybrook.ca    Contact: Lindsay McCaw, MSc    416-480-6100 ext 4244    lindsay.mccaw@sunnybrook.ca    Principal Investigator: david e spaner, MD          Sunnybrook Odette Cancer Center Toronto, Ontario, Canada, M4N3M5 Less <<
NCT03731234 DLBCL PHASE2 ACTIVE_NOT_RECRUITING 2025-07-27 Ospedale di Castelfranco Venet... More >>o - Oncoematologia IOV, Castelfranco Veneto, Treviso, 31033, Italy|A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia, Alessandria, 15121, Italy|Università Politecnica delle Marche- Clinica di Ematologia, Ancona, 60121, Italy|Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, 83100, Italy|Centro Riferimento Oncologico- S.O.C. Oncologia Medica A, Aviano, 33081, Italy|IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, 70121, Italy|ASST Spedali Civili di Brescia - Ematologia, Brescia, 25123, Italy|Ospedale Businco - SC Ematologia e CTMO, Cagliari, 09121, Italy|Arnas Nuovo Ospedale Garibaldi Nesima - U.O.C. Ematologia, Catania, 95123, Italy|Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Firenze, 50141, Italy|Ospedale Policlinico San Martino S.S.R.L- IRCCS per l'Oncologia - Ematologia, Genova, 16132, Italy|Azienda Ospedali Riuniti Papardo-Piemonte - S.C. Ematologia, Messina, 98158, Italy|Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia, Milano, 20132, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia, Milano, 20133, Italy|IEO Istitito Europeo di Oncologia - Divisione Ematoncologia, Milano, 20141, Italy|ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, 20162, Italy|Azienda Ospedaliero-Universitaria Policlinico di Modena - Ematologia, Modena, 41123, Italy|Monza - Fondazione IRCCS San Gerardo dei Tintori - Ematologia, Monza, 20900, Italy|Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - UOC Ematologia Oncologica, Napoli, 80131, Italy|AOU Maggiore della Carità di Novara - SCDU Ematologia, Novara, 28100, Italy|I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1, Padova, 35128, Italy|IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia, Pavia, 27100, Italy|P.O. Spirito Santo di Pescara - UOS Dipartimentale - Centro di diagnosi e Terapia dei linfomi, Pescara, 65124, Italy|Ospedale Guglielmo da Saliceto - U.O.Ematologia, Piacenza, 29121, Italy|AOU Pisana - U.O. Ematologia, Pisa, 56126, Italy|A.O.R. "San Carlo" - U.O. Ematologia, Potenza, 85100, Italy|Ospedale delle Croci - Ematologia, Ravenna, Italy|Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia -, Reggio Emilia, 42123, Italy|Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, 47923, Italy|Dipartimento di Medicina Traslazionale e di Precisione, Università 'La Sapienza', Roma, Italy|Università Cattolica S. Cuore - Ematologia, Roma, Italy|Casa Sollievo della Sofferenza - UO Ematologia, San Giovanni Rotondo, Italy|A.O. S. Maria di Terni - S.C. Oncoematologia, Terni, Italy|A.O.U. Citta della Salute e della Scienza di Torino - Centro Ematologia Universitaria, Torino, 10126, Italy|A.O.U. Citta della Salute e della Scienza di Torino - S.C.Ematologia, Torino, 10126, Italy|A.O. C. Panico - U.O.C Ematologia e Trapianto, Tricase, 73039, Italy|Azienda Sanitaria Universitaria Integrata Trieste (ASUITS) SC Ematologia, Trieste, Italy|Ospedale Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine)-SOC Clinica Ematologica, Udine, 33100, Italy|Ospedale di Circolo U.O.C Ematologia, Varese, Italy Less <<
NCT03207555 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic|Chronic Lymphocytic Leukemia|Small Lymphocytic Leukemia Less << PHASE2 COMPLETED 2024-08-02 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT03310190 - Recruiting June 15, 2020 Canada, Alberta ... More >> University of Calgary /ID# 166416 Recruiting Calgary, Alberta, Canada, T2N 4Z6 Cross Cancer Institute /ID# 166417 Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Canada, New Brunswick The Moncton Hospital /ID# 166043 Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Saint John Regional Hospital /ID# 202190 Not yet recruiting Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario William Osler Health System /ID# 202049 Not yet recruiting Brampton, Ontario, Canada, L6R 3J7 Michael Garron Hospital/Toronto East Health Network /ID# 209463 Not yet recruiting East York, Ontario, Canada, M4C 3E7 Kingston Health Sciences Centr /ID# 169252 Recruiting Kingston, Ontario, Canada, K7L 2V7 The Ottawa Hospital Research /ID# 166041 Recruiting Ottawa, Ontario, Canada, K1H 8L6 Health Sciences North /ID# 205817 Recruiting Sudbury, Ontario, Canada, P3N 1H5 Canada, Quebec Jewish General Hospital /ID# 166418 Recruiting Montreal, Quebec, Canada, H3T 1E2 Cisss Du Bas-Saint-Laurent Hopital Regional de Rimouski /Id# 201202 Recruiting Rimouski, Quebec, Canada, G5L 5T1 Canada CancerCare Manitoba /ID# 170751 Recruiting Manitoba, Canada, R3E 0V9 Thunder Bay Regional Health Re /ID# 204740 Not yet recruiting Thunder Bay, Canada, P7B 6V4 Less <<
NCT03740529 Chronic Lymphocytic Leukemia ... More >> Waldenstrom's Macroglobulinemia Mantle Cell Lymphoma Marginal Zone Lymphoma B-cell Lymphoma Small Lymphocytic Lymphoma Less << Phase 1 Phase 2 Recruiting April 2021 United States, Tennessee ... More >> Sarah Cannon Research Institute at Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Contact: Ian W Flinn, MD, PhD Less <<
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT03235544 Lymphoma Phase 2 Recruiting May 2021 -
NCT03144674 Lymphoma Phase 2 Recruiting March 2022 -
NCT02141282 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting December 8, 2021 United States, California ... More >> Ucsd /Id# 128535 La Jolla, California, United States, 92037 University of California, Los Angeles /ID# 127262 Los Angeles, California, United States, 90095 Stanford Univ School of Med /ID# 126495 Stanford, California, United States, 94305-2200 United States, District of Columbia Medstar Georgetown Univ Med Ct /ID# 127261 Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Hospital /ID# 131249 Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University /ID# 126497 Chicago, Illinois, United States, 60611-2927 United States, Massachusetts Beth Israel Deaconess Med Ctr /ID# 134509 Boston, Massachusetts, United States, 02215-5400 Dana-Farber Cancer Institute /ID# 126496 Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Rochester /ID# 130013 Rochester, Minnesota, United States, 55905-0001 United States, New York Columbia Univ Medical Center /ID# 128536 New York, New York, United States, 10032-3725 New York Presbyterian Hospital - Weill Cornell Medical Center /ID# 129648 New York, New York, United States, 10032-3725 Univ Rochester Med Ctr /ID# 130011 Rochester, New York, United States, 14642 United States, Ohio The Ohio State University - Columbus /ID# 127263 Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania /ID# 126860 Philadelphia, Pennsylvania, United States, 19104-5502 United States, Texas Univ TX, MD Anderson /ID# 126498 Houston, Texas, United States, 77030 United States, Utah University of Utah /ID# 129984 Salt Lake City, Utah, United States, 84112-5500 University of Utah /ID# 130813 Salt Lake City, Utah, United States, 84112-5500 Less <<
NCT02742090 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting December 2019 United States, District of Col... More >>umbia TG Therapeutics Investigational Trial Site Washington, District of Columbia, United States, 20007 United States, Florida TG Therapeutics Investigational Trial Site Fort Myers, Florida, United States, 33916 TG Therapeutics Investigational Trial Site Saint Petersburg, Florida, United States, 33705 United States, Missouri TG Therapeutics Investigational Trial Site Kansas City, Missouri, United States, 64132 United States, New Hampshire TG Therapeutics Investigational Trial Site Lebanon, New Hampshire, United States, 03756 United States, New Jersey TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States, 07601 United States, New York TG Therapeutics Investigational Trial Site New Hyde Park, New York, United States, 11042 TG Therapeutics Investigational Trial Site New York, New York, United States, 10032 TG Therapeutics Investigational Trial Site Rochester, New York, United States, 14642 United States, North Carolina TG Therapeutics Investigational Trial Site Durham, North Carolina, United States, 27710 United States, Pennsylvania TG Therapeutics Investigational Trial Site Hershey, Pennsylvania, United States, 17033 TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States, 19146 United States, Tennessee TG Therapeutics Investigational Trial Site Nashville, Tennessee, United States, 37203 United States, Washington TG Therapeutics Investigational Trial Site Seattle, Washington, United States, 98104 Less <<
NCT02639910 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Less << Phase 2 Active, not recruiting - United States, Florida ... More >> Clinical Study Site Jacksonville, Florida, United States, 32204 United States, Minnesota Clinical Study Site Rochester, Minnesota, United States, 55905 United States, Ohio Clinical Study Site Columbus, Ohio, United States, 43210 Austria Clinical Study Site Graz, Austria, 8036 Clinical Study Site Salzburg, Austria, 5020 Clinical Study Site Wien, Austria, 1090 Germany Clinical Study Site Dresden, Germany, 1307 Clinical Study Site Leipzig, Germany, 4103 Clinical Study Site Muenchen, Germany, 80804 Italy Clinical Study Site Brescia, Italy, 25123 Clinical Study Site Milano, Italy, 20162 Poland Clinical Study Site Gdansk, Poland, 80952 Clinical Study Site Krakow, Poland, 30510 Clinical Study Site Lublin, Poland, 85094 Clinical Study Site Opole, Poland, 45372 United Kingdom Clinical Study Site Bournemouth, United Kingdom, BH7 7DW Clinical Study Site Leeds, United Kingdom, LS9 7TF Less <<
NCT03570892 Non-Hodgkin Lymphoma Phase 3 Not yet recruiting May 26, 2025 -
NCT02559583 - Completed - Argentina ... More >> Buenos Aires, Argentina Ciudad Autonoma De Buenos Aires, Argentina Cordoba, Argentina La Plata Lpl Lpl, Argentina Brazil Belo Horizonte, Brazil Fortaleza, Brazil Goiânia, Brazil Porto Alegre, Brazil Sao Jose Do Rio Preto, Brazil Sao Paulo, Brazil São Paulo, Brazil Chile Santiago, Chile Colombia Bogota N/A, Colombia Bogota, Colombia Bogotá Dc, Colombia Cali, Colombia Floridablanca, Colombia Medellín, Colombia Guatemala Guatemala City, Guatemala Mexico Ciudad De Mexico, Mexico Huixquilucan, Mexico Mexico City, Mexico Mexico Df, Mexico Mexico, Mexico Monterrey, Mexico Toluca, Mexico Panama Panama Republic Panama, Panama Panama, Panama Less <<
NCT03604692 Chronic Graft-versus-host-dise... More >>ase Less << Phase 1 Recruiting March 1, 2020 United States, Minnesota ... More >> University of Minnesota Medical Center Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Mukta Arora, MD       arora005@umn.edu    United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37212-3505 Contact: Madan H Jagasia, MD    800-811-8480    madan.jagasia@vanderbilt.edu    United States, Washington Fred Hutchinson Cancer Research Center Not yet recruiting Seattle, Washington, United States, 98109 Contact: Stephanie Lee, MD       sjlee@fredhutch.org Less <<
NCT03370185 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Suspended(Reassessing corporat... More >>e priorities.) Less << March 2021 United States, Arizona ... More >> Arizona Oncology Tempe, Arizona, United States, 85284 United States, Arkansas Genesis Cancer Center Hot Springs, Arkansas, United States, 71913 United States, California Moores UC San Diego Cancer Center La Jolla, California, United States, 92093 United States, Illinois Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, Michigan QUEST Research Institute Royal Oak, Michigan, United States, 48073 United States, Montana St. Vincent Frontier Cancer Center Billings, Montana, United States, 59102 United States, New Jersey Summit Medical Group Morristown, New Jersey, United States, 07932 United States, Washington Medical Oncology Associates PS, WA Spokane, Washington, United States, 99208 Less <<
NCT03265717 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 2 Recruiting March 2022 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Philip Thompson, MD    713-794-1602    PAThompson2@mdanderson.org Less <<
NCT02733042 Lymphoma Leuk... More >>emia, Lymphocytic, Chronic, B-Cell Less << Phase 1 Phase 2 Active, not recruiting July 8, 2022 -
NCT02455297 Lymphoma, Mantle-Cell Phase 2 Terminated - United States, Maryland ... More >> Baltimore, Maryland, United States, 21287 United States, New Jersey Hackensack, New Jersey, United States, 07601 United States, New York New York, New York, United States, 10021 New York, New York, United States, 10029 United States, Vermont Burlington, Vermont, United States, 05401 Less <<
NCT03702231 Safety and Tolerability ... More >> Compare SHINGRIX Vaccine Response Rates Less << Phase 2 Recruiting May 15, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03331198 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Lymphoma, Small Lymphocytic Less << Phase 1 Phase 2 Recruiting March 1, 2022 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Hormoz Mirshkarlo, MD    626-256-4673 ext 69074    hmirshkarlo@coh.org    Principal Investigator: Tanya Siddiqi, MD          UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Krisma C Montalvo    858-246-0386    kcmontalvo@ucsd.edu    Contact: Natalie McCarthy    858-822-0743    nmccarthy@ucsd.edu    Principal Investigator: Thomas J Kipps, MD, PhD          United States, Illinois University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Sadi Dixon, RN    773-702-2070    sdixon2@medicine.bsd.uchicago.edu    Contact: John Tyson    773-702-9440    jtyson3@medicine.bsd.uchicago.edu    Principal Investigator: Peter Riedell, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jacob D Soumerai, MD    617-724-4000    jsoumerai@mgh.harvard.edu    Principal Investigator: Jacob D Soumerai, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Emma Logan, RN    617-667-5984    eklogan@bidmc.harvard.edu    Principal Investigator: Jon Arnason, MD          United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Philip Chicci    215-955-3758    Philip.Chicchi@jefferson.edu    Contact: Neil McElhenney    215-503-1011    Neil.McElhenney@jefferson.edu    Principal Investigator: Matthew Carabasi, MD          UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Linda Fukas          Contact    412-623-6037    fukaslj@upmc.edu    Principal Investigator: Kathleen Dorritie, MD          United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: William G Wierda, MD, PhD    713-792-7026    wwierda@mdanderson.org    Principal Investigator: William G Wierda, MD, PhD          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Kolleen Hicks, BS    801-587-7604    Kolleen.Hicks@hci.utah.edu    Contact: Natalie Tullis, BSN    801-213-6098    Natalie.Tullis@hci.utah.edu    Principal Investigator: Deborah Stephens, DO Less <<
NCT02352558 Hematologic Malignancy Phase 1 Active, not recruiting - United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Tennessee West Clinic Germantown, Tennessee, United States, 38138 United States, Texas Cancer Care Centers of South Texas San Antonio, Texas, United States, 78217 Cancer Care Centers of South Texas - HOAST San Antonio, Texas, United States, 78229 United States, Virginia Virginia Cancer Specialists, P.C. Fairfax, Virginia, United States, 22031 Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists, PC Vancouver, Washington, United States, 98684 Less <<
NCT02414022 - Active, not recruiting December 2020 Canada, Ontario ... More >> Stronach Regional Health Centre at Southlake Newmarket, Ontario, Canada, L3Y 2P9 Less <<
NCT03685708 Hepatitis Saf... More >>ety and Tolerability Less << Phase 2 Recruiting May 15, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02005289 Contiguous Stage II Small Lymp... More >>hocytic Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Active, not recruiting October 31, 2018 United States, Ohio ... More >> The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT01644253 Chronic Lymphocytic Leukemia ... More >> Peripheral T-cell Lymphoma Less << Phase 1 Active, not recruiting December 2019 United States, Georgia ... More >> Augusta, Georgia, United States, 30912 United States, Ohio Columbus, Ohio, United States, 43210 United States, South Carolina Greenville Health System Greenville, South Carolina, United States, 29605 United States, Texas Houston, Texas, United States, 77030 United States, Washington Swedish Cancer Institute,1221 Madison St. Seattle, Washington, United States, 98104 Less <<
NCT03572634 Chronic Lymphocytic Leukemia ... More >> CLL SLL Small Lymphocytic Lymphoma Less << Phase 1 Phase 2 Not yet recruiting April 2021 United States, Minnesota ... More >> Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Neil Kay, MD          Principal Investigator: Neil Kay, MD Less <<
NCT03219047 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Mantle Cell Lymphoma Less << Early Phase 1 Not yet recruiting September 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       miwang@mdanderson.org Less <<
NCT02436707 Lymphoma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Douglas A. Stewart    403 521-3347       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Neil Sun Chua    780 432-8340       Canada, British Columbia BCCA - Vancouver Cancer Centre Suspended Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Suspended Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Contact: Nizar Abdel-Samad    506 870-2404       The Vitalite Health Network - Dr. Leon Richard Suspended Moncton, New Brunswick, Canada, E1C 8X3 Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Stephen Couban    902 473-8562       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Graeme Fraser    905 575-7820       Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Annette Hay    613 533-6430 ext 77094       Ottawa Hospital Research Institute Suspended Ottawa, Ontario, Canada, K1H 8L6 Odette Cancer Centre Suspended Toronto, Ontario, Canada, M4N 3M5 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: John Kuruvilla    416 946-2827       Canada, Quebec CIUSSS de l'Est-de-I'lle-de-Montreal Suspended Montreal, Quebec, Canada, H1T 2M4 CHUM-Centre Hospitalier de l'Universite de Montreal Suspended Montreal, Quebec, Canada, H2X 3E4 CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Quebec City, Quebec, Canada, G1J 1Z4 Contact: Jean-Francois Larouche    418 649-5726       Canada, Saskatchewan Allan Blair Cancer Centre Suspended Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT03642236 FLT3-ITD Mutation|Acute Myeloi... More >>d Leukemia|Brutons Tyrosine Kinase Less << PHASE2|PHASE3 UNKNOWN 2025-09-23 Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less <<
NCT02787369 Recurrent Chronic Lymphoid Leu... More >>kemia Less << Phase 1 Active, not recruiting April 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01500733 Leukemia Leuk... More >>emia, Lymphocytyc CLL (Chronic Lymphocytic Leukemia) SLL (Small Lymphocytic Lymphoma) Less << Phase 2 Active, not recruiting May 1, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02640209 LYMPHOCYTIC LEUKEMIA (CLL) OR ... More >>SMALL LYMPHOCYTIC LYMPHOMA (SLL) Less << Not Applicable Active, not recruiting October 2019 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03469895 - Active, not recruiting July 2018 France ... More >> Institut Paoli Calmettes Marseille, Bouches Du Rhone, France, 13009 Less <<
NCT02267590 - Unknown October 2016 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Sunil Iyengar    020 8661 3202    sunil.iyengar@rmh.nhs.uk    Contact: Lorna Smith    020 8661 3018    lorna.smith2@rmh.nhs.uk Less <<
NCT03440567 CCND1 Positive ... More >> CD20 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mantle Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mantle Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Less << Phase 1 Recruiting June 8, 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Liana Nikolaenko, MD    626-256-4673    lnikolaenko@coh.org    Principal Investigator: Liana Nikolaenko, MD Less <<
NCT01479842 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Active, not recruiting December 31, 2018 United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT03569137 - Not yet recruiting August 1, 2020 France ... More >> CHU de Nantes Not yet recruiting Nantes, France Contact: Emmanuel Montassier, MD    0253482038    emmanuel.montassier@chu-nantes.fr    Principal Investigator: Emmanuel Montassier, MD Less <<
NCT03751410 - Not yet recruiting December 2020 -
NCT03223610 Lymphoma Non-... More >>Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Burkitt Lymphoma Less << Phase 1 Recruiting September 1, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01820936 Healthy Volunteers Phase 1 Completed - United States, New Jersey ... More >> Neptune, New Jersey, United States Less <<
NCT01500733 - Active, not recruiting - -
NCT02332980 Recurrent Chronic Lymphocytic ... More >>Leukemia Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Nodal Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Splenic Marginal Zone Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Nodal Marginal Zone Lymphoma Refractory Small Lymphocytic Lymphoma Refractory Splenic Marginal Zone Lymphoma Richter Syndrome Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting January 5, 2020 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Jose F. Leis          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Wei Ding Less <<
NCT00849654 B-Cell Lymphoma|B-Cell Leukemi... More >>a Less << PHASE1 COMPLETED 2025-07-12 Stanford University School of ... More >>Medicine, Palo Alto, California, 94305, United States|University of Chicago, Chicago, Illinois, 60637, United States|National Cancer Institute, Bethesda, Maryland, 20892-1203, United States|New York Prebyterian Hospital Cornell Medical Center, New York, New York, 10065, United States|Willamette Valley Cancer Institute/Research Ctr, Eugene, Oregon, 97401, United States|University of Texas, MD Anderson, Houston, Texas, 77030, United States|University of Vermont College of Medicine, Burlington, Vermont, 05405, United States|Northwest Cancer Specialists, Vancouver Cancer Center, Vancouver, Washington, 98684, United States|Yakima Valley Memorial Hospital/North Star Lodge Cancer Ctr, Yakima, Washington, 98902, United States Less <<
NCT02950051 Chronic Lymphocytic Leukemia Phase 3 Recruiting January 2024 -
NCT01292135 B-cell Chronic Lymphocytic Leu... More >>kemia|Small Lymphocytic Lymphoma Less << PHASE1 COMPLETED 2025-05-13 Dana Farber Cancer Center, Bos... More >>ton, Massachusetts, 02115, United States|CLL Research and Treatment Program, New Hyde Park, New York, 11042, United States|Weill Medical College of Cornell University, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson, Houston, Texas, 77030, United States Less <<
NCT02954406 Lymphoma, Non-Hodgkin Phase 1 Recruiting April 26, 2019 United States, Arizona ... More >> University of Arizona Cancer Center, Tucson Recruiting Tucson, Arizona, United States, 85724 United States, California University of California San Diego (UCSD) - Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Cedars-Sinai Medical Center (CSMC) - Samuel Oschin Comprehensive Cancer Institute Not yet recruiting West Hollywood, California, United States, 90048 United States, Kentucky University of Louisville Kentucky James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 United States, Maryland Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Massachusetts Tufts Medical Center Not yet recruiting Boston, Massachusetts, United States, 02111 United States, Michigan Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202-2608 United States, New York NYU Langone Medical Center - NYU Medical Oncology Associates Recruiting New York, New York, United States, 10016-4744 United States, North Carolina University of North Carolina - Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 United States, Ohio University Hospitals of Cleveland Recruiting Cleveland, Ohio, United States, 44106 United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec McGill University - Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01292135 B-cell Chronic Lymphocytic Leu... More >>kemia|Small Lymphocytic Lymphoma Less << PHASE1 COMPLETED 2025-05-13 Dana Farber Cancer Center, Bos... More >>ton, Massachusetts, 02115, United States|CLL Research and Treatment Program, New Hyde Park, New York, 11042, United States|Weill Medical College of Cornell University, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson, Houston, Texas, 77030, United States Less <<
NCT03502876 - Active, not recruiting August 2018 France ... More >> FILO French Innovative Leukemia Organization Tours, France, 37044 Project manager Tours, France, 37044 Less <<
NCT01520519 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02846623 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Recruiting January 1, 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       njain@mdanderson.org Less <<
NCT01776840 Mantle Cell Lymphoma Phase 3 Active, not recruiting October 12, 2021 -
NCT01109069 B-cell Chronic Lymphocytic Leu... More >>kemia|Small Lymphocytic Lymphoma|Diffuse Well-differentiated Lymphocytic Lymphoma|B Cell Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|Non-Hodgkin's Lymphoma|Waldenstrom Macroglobulinemia|Burkitt Lymphoma|B-Cell Diffuse Lymphoma Less << PHASE2 COMPLETED 2019-04-26 Stanford University, Stanford,... More >> California, 94305, United States|Stanford, California, 94305, United States|University of Chicago, Chicago, Illinois, 60637, United States|Boston, Massachusetts, 02215, United States|New Hyde Park, New York, 11042, United States|New York, New York, 10065, United States|Rochester, New York, 14642-0001, United States|Columbus, Ohio, 43210, United States|Springfield, Oregon, 97477, United States|Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Houston, Texas, 77030, United States|Tyler, Texas, 75702, United States|Fletcher Allen Health Care and University of Vermont, Burlington, Vermont, 05405, United States|Vancouver, Washington, 98684, United States|Yakima Valley Memorial Hospital/North Star Lodge, Yakima, Washington, 98902, United States Less <<
NCT01962792 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting April 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 University of California Los Angeles Los Angeles, California, United States, 90095 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York New York Presbyterian Hospital - Weill-Cornell New York, New York, United States, 10021 Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Carolinas Healthcare System Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina MUSC Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Methodist Healthcare System San Antonio, Texas, United States, 78229 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Canada, Quebec McGill University Montreal, Quebec, Canada, QC H4A 3J1 Less <<
NCT01974440 Lymphoma Phase 3 Active, not recruiting August 3, 2021 -
NCT02824159 - Recruiting November 2020 France ... More >> Cancer University Institute of Toulouse Oncopole Recruiting Toulouse, France, 31059 Contact: Guy Laurent, MD    5 31 15 62 09 ext +33    Laurent.guy@iuct-oncopole.fr    Contact: Sandra Debaros    5.61.14.59.89 ext +33    debarros.s@chu-toulouse.fr Less <<
NCT02203526 Primary Central Nervious Syste... More >>m Lymphoma Less << Phase 1 Recruiting June 15, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02666898 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 2 Completed - France ... More >> Sponsor FILO Tours, France, 37054 Less <<
NCT03528941 - Not yet recruiting June 30, 2019 Italy ... More >> Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma Not yet recruiting Roma, Italy Contact: Gianluigi Reda          Principal Investigator: Gianluigi Reda Less <<
NCT03204188 CLL SLL Phase 2 Recruiting December 31, 2030 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02557516 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Active, not recruiting June 2019 United States, Ohio ... More >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01105247 B-cell Chronic Lymphocytic Leu... More >>kemia|Small Lymphocytic Lymphoma Less << PHASE1|PHASE2 COMPLETED 2025-02-13 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|New York Presbyterian Hosptial Cornell Med Center, New York, New York, 10065, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Willamette Valley Cancer Institute and Research Center, Springfield, Oregon, 97477, United States|Sarah Cannon, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|University of Vermont and Fletcher Allen Health Care, Burlington, Vermont, 05405, United States|Northwest Cancer Specialists, P.C., Vancouver, Washington, 98686, United States|Yakima Valley Memorial, Yakima, Washington, 98902, United States Less <<
NCT01105247 B-cell Chronic Lymphocytic Leu... More >>kemia|Small Lymphocytic Lymphoma Less << PHASE1|PHASE2 COMPLETED 2025-02-13 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|New York Presbyterian Hosptial Cornell Med Center, New York, New York, 10065, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Willamette Valley Cancer Institute and Research Center, Springfield, Oregon, 97477, United States|Sarah Cannon, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|University of Vermont and Fletcher Allen Health Care, Burlington, Vermont, 05405, United States|Northwest Cancer Specialists, P.C., Vancouver, Washington, 98686, United States|Yakima Valley Memorial, Yakima, Washington, 98902, United States Less <<
NCT02048813 Anemia Chroni... More >>c Lymphocytic Leukemia Fatigue Fever, Sweat, and Hot Flashes Hepatomegaly Lymphadenopathy Lymphocytosis Small Lymphocytic Lymphoma Splenomegaly Thrombocytopenia Weight Change Less << Phase 3 Active, not recruiting - -
NCT02406742 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Phase 2 Active, not recruiting June 9, 2020 United States, California ... More >> University of California San Diego La Jolla, California, United States, 92093 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Cornell Medical College Dr. Feldman's Office New York, New York, United States, 10065 United States, Ohio Ohio State University Medical CenterJames Cancer Hospital Columbus, Ohio, United States, 43210 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Texas MD Anderson Cancer Center The University of Texas Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98118 Austria University Hospital Innsbruck Innsbruck, Austria, 6020 University Hospital of Salzburg St Johanns Spital Salzburg, Austria, 5020 Allgemeines Krankenhaus Wien Wien, Austria, 1090 Germany Universitaetsklinikum EssenInnere Klinik und Poliklinik Essen, Germany, 45147 University of Schleswig-Holstein Kiel, Germany, 24116 Universitat zu Koln Köln, Germany, 50937 Universitatsklinikum Würzburg Würzburg, Germany, 97080 Italy Fondazione Centro San Raffaele del Monte Tabor Milano, Italy, 20132 Ospedale Niguarda Milano Milano, Italy, 20162 Arcispedale Santa Maria Nuova Reggio Emilia, Italy, 42100 Istituto Clinico Humanitas Rozzano (MI), Italy, 20089 Spain Hospital Universitario Vall D hebron Barcelona, Spain, 08035 Fundacion Jimenez Daaz Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen Del Rocio Sevilla, Spain, 41013 Less <<
NCT01478581 Multiple Myeloma Phase 2 Active, not recruiting August 2018 United States, California ... More >> SITE-13 La Jolla, California, United States, 92093 United States, Maryland SITE-5 Baltimore, Maryland, United States, 21287 United States, Massachusetts SITE-4 Boston, Massachusetts, United States, 02215 United States, Michigan SITE-8 Ann Arbor, Michigan, United States, 48109 United States, Missouri SITE-2 Saint Louis, Missouri, United States, 63110 United States, New Jersey SITE-6 Hackensack, New Jersey, United States, 07601 United States, New York SITE-10 New York, New York, United States, 10029 SITE-3 New York, New York, United States, 10065 United States, Tennessee SITE-1 Nashville, Tennessee, United States, 37203 United States, Texas SITE-11 Dallas, Texas, United States, 75390 United States, Washington SITE-9 Seattle, Washington, United States, 98109 Less <<
NCT02858258 Mantle Cell Lymphoma Phase 3 Recruiting May 2026 -
NCT01217749 - Completed - -
NCT02950220 B-Cell Lymphoma, Unclassifiabl... More >>e, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Grade 1 Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Mediastinal Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Waldenstrom Macroglobulinemia Refractory B-Cell Non-Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Less << Phase 1 Active, not recruiting December 16, 2019 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT01478581 - Active, not recruiting - -
NCT01236391 Mantle Cell Lymphoma PHASE2 COMPLETED 2025-01-14 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Cll Research and Treatment Program, New Hyde Park, New York, 11042, United States|New York Presbyterian Hospital/Cornell Medical Center, New York, New York, 94305, United States|The Ohio Sate university, Columbus, Ohio, 43210, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia School of Medicine Hospital, Charlottesville, Virginia, 22908, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Klinikum der Universitat Munchen - Campus Grosshadern, Munchen, D - 81377, Germany|Universitatsklinikum Ulm, Klinik fur Innere Medizin II, ULM, 89081, Germany|Oddzail Kliniczny Onkologil, Bydgoszcz, 85-796, Poland|Malopolskie Centrum Medyczne, Krakow, 30-510, Poland|MTZ Clinical Research Sp. z o.o., Warsaw, 02-106, Poland|Centre for Experimental Cancer Medicine, London, EC1M6BQ, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom Less <<
NCT01886872 CD19 Positive ... More >> CD20 Positive CD5 Positive Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 3 Active, not recruiting - -
NCT01217749 B-cell Chronic Lymphocytic Leu... More >>kemia Small Lymphocytic Lymphoma Prolymphocyctic Leukemia Richter's Transformation Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02401048 Diffuse Large B-Cell Lymphoma ... More >> Follicular Lymphoma Less << Phase 1 Phase 2 Active, not recruiting July 2018 United States, Alabama ... More >> Site-0397 Birmingham, Alabama, United States, 35294 United States, California Site-0047 Duarte, California, United States, 91010 Site-0038 Stanford, California, United States, 94305 United States, Florida Site-0388 Miami, Florida, United States, 33136 United States, Illinois Site-0126 Chicago, Illinois, United States, 60637 United States, Massachusetts Site-0020/0173 Boston, Massachusetts, United States, 02114 United States, Michigan Site-0729 Ann Arbor, Michigan, United States, 48109 Site-0130 Detroit, Michigan, United States, 48201 United States, New Jersey Site-0343 Hackensack, New Jersey, United States, 07601 United States, Pennsylvania Site-0402 Philadelphia, Pennsylvania, United States, 19104 United States, Washington Site-0114 Seattle, Washington, United States, 98104 Less <<
NCT02443077 Diffuse Large B-Cell Lymphoma ... More >>Activated B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 3 Suspended(Other - This protoco... More >>l requires a DTL.) Less << - -
NCT02735876 Mantle Cell Lymphoma Phase 3 Withdrawn - -
NCT01236391 Mantle Cell Lymphoma PHASE2 COMPLETED 2025-01-14 Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Cll Research and Treatment Program, New Hyde Park, New York, 11042, United States|New York Presbyterian Hospital/Cornell Medical Center, New York, New York, 94305, United States|The Ohio Sate university, Columbus, Ohio, 43210, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia School of Medicine Hospital, Charlottesville, Virginia, 22908, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Klinikum der Universitat Munchen - Campus Grosshadern, Munchen, D - 81377, Germany|Universitatsklinikum Ulm, Klinik fur Innere Medizin II, ULM, 89081, Germany|Oddzail Kliniczny Onkologil, Bydgoszcz, 85-796, Poland|Malopolskie Centrum Medyczne, Krakow, 30-510, Poland|MTZ Clinical Research Sp. z o.o., Warsaw, 02-106, Poland|Centre for Experimental Cancer Medicine, London, EC1M6BQ, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom Less <<
NCT01855750 Lymphoma Phase 3 Active, not recruiting June 16, 2020 -
NCT01973387 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Completed - Australia ... More >> Concord, Australia Gosford, Australia Heidelberg, Australia Perth, Australia Tweed Heads, Australia China Beijing, China Chendu, China Fuzhou, China Guangzhou, China Jinan, China Nanjing, China Qingdao, China Shanghai, China Suzhou, China Tianjin, China Unk Hangzhou, China Wuhan, China Xian, China Malaysia Johor Bahru, Malaysia Kuala Lumpur, Malaysia Melaka, Malaysia Subang Jaya, Malaysia Taiwan Changhua, Taiwan Kaohsiung, Taiwan Tainan, Taiwan Taipei, Taiwan Less <<
NCT02341781 - Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Phoenix, Arizona, United States, 85054 United States, California Innovative Clinical Research Institute Whittier, California, United States, 90603 United States, Florida University of Miami and Sylvester Comprehensive Cancer Miami, Florida, United States, 33136 United States, Michigan University of Michigan Comprehensive Cancer Center Division of Hematology Oncology Ann Arbor, Michigan, United States, 48109 United States, Missouri Columbia Comprehensive Cancer Care Clinic Jefferson City, Missouri, United States, 65101 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitatsmedizin der Johannes Gutenberg- Universitat Mainz, Rhineland-Palatinate, Germany, 55131 Italy Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi Bologna, Emilia-Romagna, Italy, 40138 United Kingdom Derriford Hospital Plymouth Oncology Center Clinical Plymouth, Devon, United Kingdom, Pl68DH Less <<
NCT02629809 Chronic Lymphocytic Leukemia ... More >> Immunoglobulin Heavy Chain Locus Variable Region Mutation Small Lymphocytic Lymphoma Less << Phase 2 Recruiting March 31, 2022 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nitin Jain    713-745-6080       Principal Investigator: Nitin Jain Less <<
NCT01973387 - Completed - -
NCT02077166 Relapsed Diffuse Large B-Cell ... More >>Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Active, not recruiting October 2020 -
NCT02460276 Relapsed/Refractory Mantle Cel... More >>l Lymphoma Less << Phase 2 Recruiting March 2019 Denmark ... More >> Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Martin Hutchings, MD, PhD       martin.hutchings@regionh.dk    Principal Investigator: Martin Hutchings, MD, PhD          Finland Helsinki University Hospital Not yet recruiting Helsinki, Finland Contact: Riikka Räty, MD, PhD    +358 10 328 1900    riikka.raty@hus.fi    Principal Investigator: Riikka Räty, MD, PhD          Norway Norwegian Radium Hospital Not yet recruiting Oslo, Norway, 0424 Contact: Arne Kolstad, MD, PhD    +47 915 02 770    arne.kolstad@oslo-universitetssykehus.no    Principal Investigator: Arne Kolstad, MD, PhD          Sweden Lund University Hospital Recruiting Lund, Sweden, 221 85 Contact: Mats Jerkeman, MD, PhD    +46 46 17 75 20    mats.jerkeman@med.lu.se    Principal Investigator: Mats Jerkeman, MD, PhD          Uppsala Akademiska Hospital Recruiting Uppsala, Sweden, 751 85 Contact: Anna Laurell, MD, PhD    018-611 00 00    anna.laurell@akademiska.se    Principal Investigator: Anna Laurell, MD, PhD Less <<
NCT01724346 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Active, not recruiting April 30, 2023 -
NCT02142049 Diffuse Large B Cell Lymphoma ... More >>Relapsed Diffuse Large B Cell Lymphoma Refractory Less << Phase 1 Phase 2 Unknown November 2017 United States, California ... More >> SITE-1 Duarte, California, United States, 91010 SITE-2 Los Angeles, California, United States, 90095 SITE-10 Orange, California, United States, 92868 United States, Illinois SITE-3 Chicago, Illinois, United States, 60612 United States, Maryland SITE-5 Baltimore, Maryland, United States, 21201 SITE-6 Bethesda, Maryland, United States, 20892 United States, Michigan SITE-4 Ann Arbor, Michigan, United States, 48109 United States, New Mexico SITE-8 Albuquerque, New Mexico, United States, 87106 United States, New York SITE-9 Stony Brook, New York, United States, 11794 United States, South Carolina SITE-7 Charleston, South Carolina, United States, 29425 Less <<
NCT02717611 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting February 2020 -
NCT02643667 Prostate Cancer Phase 1 Phase 2 Suspended(The study closed at ... More >>UCSF and the study moved to Washington University. Waiting on IRB approval at Washington University.) Less << March 31, 2021 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94158 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02548962 Multiple Myeloma Phase 1 Phase 2 Terminated(After completing Ph... More >>ase 1, the Sponsor elected not to move forward with Phase 2.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Australia, New South Wales Concord Repatriation General Hospital Concord, New South Wales, Australia, 2139 Australia, Queensland Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Czechia Fakultni nemocnice Brno Brno, Czechia, 625 00 Fakultni nemocnice Ostrava Ostrava, Czechia, 708 52 Vseobecna fakultni nemocnice v Praze Praha, Czechia, 128 08 Germany Universitätsklinikum Carl Gustav Carus Dresden, Germany, 01307 Greece 'Alexandra' General Hospital of Athens Athens, Attiki, Greece, 11528 Spain Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Hospital de La Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Doctor Peset Valencia, Spain, 46017 Less <<
NCT02760485 Lymphoma Phase 1 Phase 2 Recruiting July 2019 -
NCT01866033 Healthy Volunteer Phase 1 Completed - Belgium ... More >> Merksem, Belgium Less <<
NCT01611090 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Active, not recruiting January 23, 2019 -
NCT03633045 - Not yet recruiting April 30, 2022 -
NCT02264574 Chronic Lymphocytic Leukemia ... More >> Small-Cell Lymphoma Less << Phase 3 Active, not recruiting January 2020 -
NCT02518555 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Active, not recruiting November 2019 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02599324 Renal Cell Carcinoma (RCC) ... More >> Urothelial Carcinoma Gastric Adenocarcinoma Colorectal Adenocarcinoma (CRC) Less << Phase 1 Phase 2 Recruiting June 2019 -
NCT02471391 Mantle Cell Lymphoma Phase 2 Unknown June 2018 Australia, Victoria ... More >> Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 3002 Contact: Constantine Tam    +61 3 9656 1700    constantine.tam@petermac.org    Royal Melbourne Hospital Recruiting Melbourne, Victoria, Australia, 3000 Contact: Constantine Tam, MBBS (Hons), MD, FRACP, FRCPA    +61 3 9656 1700    constantine.tam@petermac.org Less <<
NCT02670616 Epstein-Barr Virus-positive Di... More >>ffuse Large B-cell Lymphoma Less << Phase 2 Recruiting June 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Seoul, Gangnam-gu, Korea, Republic of, 135-710 Contact: Wonseog Kim, M.D., Ph.D.    82-2-3410-6548    wonseog.kim@samsung.com    Sub-Investigator: Seogjin Kim, M.D., Ph.D.          Principal Investigator: Wonseog Kim, M.D. Ph.D Less <<
NCT01767948 Hepatic Impairment PHASE1 COMPLETED 2025-11-13 Costa Mesa, California, United... More >> States|Orlando, Florida, United States|Knoxville, Tennessee, United States|San Antonio, Texas, United States Less <<
NCT02390609 Healthy Phase 1 Completed - Belgium ... More >> Antwerpen, Belgium Less <<
NCT03015792 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Phase 2 Suspended(temporary closing pe... More >>r study design) Less << February 15, 2022 United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 Less <<
NCT02780830 Core: Relapsed or Refractory D... More >>iffuse Large B-Cell Lymphoma Module 1: Non-GCB Diffuse Large B-Cell Lymphoma Less << Phase 1 Withdrawn(Study D2276C00001 wa... More >>s not started. No patients were enrolled. The sponsor decided to pursue an alternate design.) Less << April 2019 -
NCT03462719 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 3 Recruiting April 30, 2024 -
NCT03697512 Marginal Zone Lymphoma ... More >> Nodal Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Less << Phase 2 Not yet recruiting April 15, 2027 France ... More >> Saint Louis Hospital Not yet recruiting Paris, France, 75010 Contact: Catherine Thieblemont, MD       Catherine.Thieblemont@athp.fr    Principal Investigator: Catherine Thieblemont, MD          Italy Ospedale degli Infermi Not yet recruiting Ponderano, BI, Italy, 13875 Contact: Annarita Conconi, MD       annarita.conconi@aslbi.piemonte.it    Principal Investigator: Annarita Conconi, MD          Switzerland Istituto Oncologico della Svizzera Italiana (IOSI) Not yet recruiting Bellinzona, TI, Switzerland, 6500 Contact: Emanuele Zucca, MD       ielsg@eoc.ch    Principal Investigator: Emanuele Zucca, MD Less <<
NCT04042376 Waldenstrom Macroglobulinemia PHASE4 COMPLETED 2024-03-19 The First Hospital of Jilin Un... More >>iversity, Changchun, 130021, China|First affiliated Hospital of Zhejiang University, Hangzhou, 310003, China|Institute of Hematology and Blood Diseases Hospital, Tianjin, 300320, China|Wuhan Union Hospital, Wuhan, 430023, China|The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China|Henan Cancer Hospital, Zhengzhou, 450008, China Less <<
NCT02195869 Graft Versus Host Disease PHASE1|PHASE2 COMPLETED 2017-09-15 City of Hope Medical Center, D... More >>uarte, California, 91010, United States|University of California, San Francisco, San Francisco, California, 94143, United States|Stanford University, Stanford, California, 94305, United States|Emory University, Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States Less <<
NCT01704963 Recurrent Mature B-cell Neopla... More >>sms Less << PHASE1 COMPLETED 2017-02-01 Kyoto, Japan|Nagoya, Japan|Sen... More >>dai, Japan|Tokyo, Japan Less <<
NCT05782374 PCNSL RECRUITING 2023-08-10 Ospedale San Raffaele, Milan, ... More >>20132, Italy Less <<
NCT03790332 Chronic Graft Versus Host Dise... More >>ase Less << PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2026-01-04 City of Hope, Duarte, Californ... More >>ia, 91010, United States|Rady Children's Hospital, San Diego, California, 92123, United States|University of California, San Francisco, California, 94158, United States|Children's Hospital, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, 33701, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, 55454, United States|Washington University, Saint Louis, Missouri, 63110, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105-2729, United States|Primary Children's Hospital, Salt Lake City, Utah, 84113, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Cancer Center for Children. The Children's Hospital at Westmead, Westmead, New South Wales, 2145, Australia|Queensland Children's Hospital, South Brisbane, Queensland, 4101, Australia|The Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Sydney Children's Hospital, Randwick, 2031, Australia|St. Anna Kinderspital, Wien, 1090, Austria|children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, V6H 3V4, Canada|CHU Sainte-Justine, Montréal, Quebec, H3T1C5, Canada|CHU Nantes - Hopital Enfant Adolescent, Nantes, 44093, France|H?pital Robert-Debré Ap-Hp, Paris, 75019, France|Charite-Universitaetsmedizin Berlin, Berlin, 13353, Germany|Hadassah Medical Centre, Jerusalem, 9112001, Israel|Schneider Children's Medical Center in Israel, Petach Tikva, 4920235, Israel|The Edmond and Lily Safra Children's Hospital, Ramat Gan, 5262100, Israel|U.O.C. Ematologia Oncoematologia Pediatrica, Pavia, PV, 27100, Italy|Fondazione MBBM-Clinica Pediatrica, Monza, 20900, Italy|Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, Roma, 00165, Italy|S.C. Farmacia Pediatrica - Presidio Ospedaliero Infantile Regina Margherita, Turin, 10126, Italy|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Seoul Saint Mary's Hospital, Seoul, 06591, Korea, Republic of|Princess Maxima Center, Utrecht, 3584 CS, Netherlands|Federal State Budgetary Institution "Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, 117997, Russian Federation|Federal State Budgetary Educational Institution of Higher Professional Education "LP.Pavlov First Saint Petersburg State Medical, Saint Petersburg, 197022, Russian Federation|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, 28009, Spain|Hospital Universitario Universitario La Paz, Madrid, 28046, Spain|Safari Day Care, Great Ormond Street Hospital, London, Greater London, WC1N 3JH, United Kingdom Less <<
NCT02582320 Chronic Lymphocytic Leukemia COMPLETED 2018-10-03 U.O.C. Ematologia e Terapia Ce... More >>llulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno, Ascoli Piceno, Italy|U.O.C di Ematologia P.O. "S.Giuseppe Moscati" - 2° piano, Aversa, Italy|UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro, Bari, Italy|Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy|Spedali Civili - Brescia - Azienda Ospedaliera - U.O. Ematologia, Brescia, Italy|Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy|ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy|US Dipartimentale - Centro per le malattie del sangue - Ospedale Civile - S.Giacomo, Castelfranco Veneto, Italy|Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia, Catanzaro, Italy|U.O. di Medicina Interna - ASUR Marche 8 - Ospedale Civile, Civitanova Marche, Italy|Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Cona, Italy|Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano, Firenze, Italy|IRCCS_AOU San Martino-IST.Clinica Ematologica, Genova, Italy|ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy|Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano, Milano, Italy|U.O. Ematologia e Trapianto di MIdollo - Ist.Scientifico Ospedale San Raffaele, Milano, Italy|Unità Trapianto di Midollo Ist. Nazionale Tumori, Milano, Italy|UO Ematologia - AOU Policlinico di Modena, Modena, Italy|Ospedale San Gennaro - ASL Napoli 1, Napoli, Italy|S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro, Novara di Sicilia, Italy|Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy|U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani, Pagani, Italy|Cattedra di Ematologia CTMO Università degli Studi di Parma, Parma, Italy|S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy|Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia, Perugia, Italy|U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy|Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto, Piacenza, Italy|Ematologia - Ospedale San Carlo, Potenza, Italy|Dipartimento Oncologico - Ospedale S.Maria delle Croci, Ravenna, Italy|Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, Reggio Emilia, Italy|Ospedale "Infermi", Rimini, Italy|U.O.C. Ematologia - IRCCS Centro oncologico della Basilicata, Rionero in Vulture, Italy|S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy|U.O.C. Ematologia - Ospedale S.Eugenio, Roma, Italy|U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita, Roma, Italy|Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy|Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy|Policlinico Umberto I, Hematology Department - Sapienza, Rome, Italy|Sezione di Ematologia Cancer Center Humanitas, Rozzano, Italy|Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte", Siena, Italy|A.O. Santa Maria - Terni S.C Oncoematologia, Terni, Italy|Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy|Divisione di Ematologia dell' Università degli Studi di Torino - "Città della Salute e della Scienza di Torino", Torino, Italy|ULSS N.6 Osp. S. Bortolo, Vicenza, Italy Less <<
NCT04094051 Chronic Lymphocytic Leukemia|S... More >>mall Lymphocytic Lymphoma Less << UNKNOWN 2021-12-31 the First Affiliated Hospital ... More >>of Nanjing Medical University, Nanjing, Jiangsu, 210000, China Less <<
NCT04398459 Refractory/Relapsed Autoimmune... More >> Hemolytic Anemia Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-06-30 Zhoukou Central Hospital, Zhou... More >>kou, Henan, China|The Second Affilated Hospital of Shandong First Medical University, Tai'an, Shandong, China|Regenerative Medicine Center, Tianjin, Tianjin, China Less <<
NCT01804686 Chronic Lymphocytic Leukemia|S... More >>mall Lymphocytic Lymphoma|Mantle Cell Lymphoma|Follicular Lymphoma|Diffuse Large B-cell Lymphoma|Waldenstrom Macroglobulinemia|Chronic Graft Versus Host Disease Less << PHASE3 RECRUITING 2027-01-29 City of Hope Cancer Center, Du... More >>arte, California, 91010, United States|University of California San Diego Medical Center, La Jolla, California, 92093, United States|University of California Los Angeles, Los Angeles, California, 90095, United States|St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange, California, 92868, United States|Stanford University Medical Center, Stanford, California, 94305, United States|Stanford University, Stanford, California, 94305, United States|Norwalk Medical Group, Norwalk, Connecticut, 06850, United States|Northwest Georgia Oncology Centers PC, Marietta, Georgia, 30060, United States|Northwestern University Hospital, Chicago, Illinois, 60611, United States|Indiana University, Goshen, Indiana, 46526, United States|Kansas University Medical Center, Westwood, Kansas, 66205, United States|Louisville Oncology Suburban - Norton Cancer Institute, Louisville, Kentucky, 40207, United States|Dana Farber Cancer Center, Boston, Massachusetts, 02215, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Battle Creek Health Systm, Battle Creek, Michigan, 49016, United States|Karmanos Cancer Institute - Wayne State University, Detroit, Michigan, 48201, United States|Washington University, Saint Louis, Missouri, 63110, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Weill Medical College of Cornell University, New York, New York, 10021, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Southeastern Medical Oncology Center, Goldsboro, North Carolina, 27534, United States|The Ohio State University- James Cancer Hospital, Columbus, Ohio, 43210, United States|Willamette Valley Cancer Center, Eugene, Oregon, 97401, United States|Kaiser Permanente, Portland, Oregon, 97227, United States|University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, 19104, United States|Avera Medical Group, Sioux Falls, South Dakota, 57105, United States|MD Anderson Cancer Center - University of Texas, Houston, Texas, 77030, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|University of Washington, Seattle, Washington, 98109, United States|West Virginia University, Morgantown, West Virginia, 26506, United States|University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research, Madison, Wisconsin, 53705, United States|CEMIC Saavedra, Ciudad Autonoma Buenos Aires, C1431, Argentina|Fundaleu, Ciudad de Buenos Aires, C1114AAP, Argentina|Royal Adelaide Hospital, Adelaide, 5000, Australia|John Fawkner Cancer Trial Centre, Coburg, 3058, Australia|Concord Hospital, Concord, 2139, Australia|Austin Health, Heidelberg, 3084, Australia|Peter MacCallum Cancer Institute, Melbourne, 3000, Australia|Royal Perth Hospital, Perth, 6847, Australia|Alfred Hospital, Prahran, 3181, Australia|Adventist Health Care Limited trading as San Clinical Trials Unit, Wahroonga, 2076, Australia|UZA, Antwerp, 2650, Belgium|A.Z. Sint Jan, Brugge, 8000, Belgium|UCL - Saint Luc, Brussels, 1200, Belgium|UZ Gent - departement oncologie, Gent, 9000, Belgium|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium|UCL Mont-Godinne, Yvoir, 5530, Belgium|Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, 20231 050, Brazil|Santa Casa da Misericórdia da Bahia - Hospital Santa Isabel, Salvador, 40050 410, Brazil|Instituto de Ensino e Pesquisa S?o Lucas, Sao Paulo, 01236-030, Brazil|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|Peking University People s Hospital, Beijing, 100044, China|Peking University Third Hospital, Beijing, 100083, China|Peking University First Hospital, Beijing, China|West China Hospital Sichuan University, Chengdu, 610041, China|Fujian Medical University, Fuzhou, 350001, China|Sun Yat-sen University Cancer Hospital, Guangzhou, 510060, China|Zhejiang University First Hospital, Hangzhou, 310003, China|Ruijin Hospital, Shanghai, 200025, China|Tangdu hospital the Fourth Military Medical, Shanxi, 710038, China|The First Affliated Hospital of Soochow University, Suzhou, China|The Institute of Hematological disease, Tianjin, 300070, China|Wuhan Union Hospital, Wuhan, 430023, China|Fundacion Santa Fe, Bogota, Colombia|Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, 681002, Colombia|Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno, 625 00, Czechia|Fakultni nemocnice Kralovske Vinohrady - Interni hematologicka klinika, Praha 10, 100 34, Czechia|Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie, Praha 2, 128 08, Czechia|Hopital Henri Mondor, Creteil, 94010, France|H?pital E. Muller, Mulhouse, 68100, France|Hopital Necker Enfants Malades, Paris cedex 15, 75743, France|HOPITAL SAINT LOUIS - Hematology / Oncology, Paris, 75010, France|Hopital Haut Leveque Service Maladie Du Sang, Pessac, 33604, France|CH LYON SUD - Hematology, Pierre Benite, 69310, France|CHU de Tours, Tours, 37044, France|Vivantes Klinikum Spandau-Klinik f. Innere Medizin H?matologie/Onkologie/Gastroenterologie - Germany, Berlin, 13589, Germany|Universit?tsklinikum Carl Gustav Carus; Med. Klinik und Poliklinik I - H?matologische Ambulanz, Haus, Dresden, 01307, Germany|Universit?tsklinikum Essen; Klinik f. H?matologie- Germany, Essen, 45122, Germany|Justus-Liebig-Universitaet - Medizinische Klinik IV, Haematologie, Gie?en, 35592, Germany|Universit?tsklinikum Heidelberg Med. Klinik IV, Heidelberg, 69120, Germany|Universit?tsklinikum des Saarlandes, Homburg/Saar, 66424, Germany|Gemeinschaftspraxis Dres. Uhle/Müller/Kr?ning/Jentsch-Ullrich - Germany, Magdeburg, 39104, Germany|OnkoNet Marburg GmbH, Marburg, 35037, Germany|Universit?tsklinikum für Innere Med. III_H?matologie, Onkologie...- Germany, Ulm, 89081, Germany|Laiko General Hospital - 1st department of Internal Medicine, Athens, 115 27, Greece|G Papanikolaou Hospital of Thessaloniki, Thessalonikis, 570 10, Greece|Semmelweis Egyetem, I. Belgyogyaszati Klinika, Budapest N/a, 1083, Hungary|Szegedi Tudomanyegyetem II. Belgyogyaszati Klinika, Szeged, 6725, Hungary|St James's Hospital, Dublin, 00000, Ireland|Haemek Medical Center, Afula, Israel|Hillel Yaffe Medical Center - Oncology, Hadera, 38100, Israel|Rambam Health Care Campus, Haifa, 31096, Israel|Rabin Medical Center Beilinson Campus, Petah Tikva, 4941492, Israel|Sheba Medical Center, Ramat-Gan, 52621, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy|DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma, 00161, Italy|A.O.Citta della Salute e della Scienza di Torino, Torino, 10126, Italy|Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, 113 8677, Japan|Hiroshima University Hospital, Hiroshima shi, 734 8551, Japan|Hokkaido University Hospital, Sapporo-shi, 060-8648, Japan|National Cancer Center, Goyang-Si, 10408, Korea, Republic of|The Catholic University of Korea Seoul St Mary s Hospital, Seoul, 06591, Korea, Republic of|Oaxaca Site Management Organization S.C., Oaxaca, 68000, Mexico|VU medisch centrum - Afd.Interne - INT, Amsterdam, 1081 HV, Netherlands|Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, 36-200, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, 41-500, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80 952, Poland|Pratia MCM Krakow, Krakow, 30 510, Poland|Oddzial Hematologii, Opole, 45-061, Poland|Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Slupsk, 76-200, Poland|Katedra I Klinika Hematologii Nowotworow Krwi I Transplantacji Szpiku, Wroclaw, 50 367, Poland|Instituto Portugues de Oncologia, Lisboa, 1600, Portugal|Hospital De Santa Maria, Lisbon, 1649-035, Portugal|Instituto Portugues de Oncologia, Porto, 4200072, Portugal|Auxilio Mutuo Cancer Center, San Juan, 00919, Puerto Rico|Arkhangelsk Regional Clinical Hospital, Arkhangelsk, 163045, Russian Federation|Chelyabinsk Regiona Onc. Center, Chelyabinsk, 454087, Russian Federation|Emergency Hospital of Dzerzhinsk, Dzerzhinsk, 606019, Russian Federation|Cancer Research Center, Moscow N/a, 115478, Russian Federation|S.P. Botkin Moscow City Clinical Hospital, Moscow, 125284, Russian Federation|Regional Clinical Hospital n.a.Semashko, Nizhni Novgorod, 603126, Russian Federation|Medical Scientific Radiology - Center, Obninsk, 249020, Russian Federation|Perm Medical Sanitary Unit#1, Perm, 614078, Russian Federation|Republican Hospital named by V.A.Baranova, Petrozavodsk, 185019, Russian Federation|Rostov Research Institute of Oncology, Rostov-Na-Donu, 344037, Russian Federation|Ryazan Regional Clinical Hospital, Ryazan, 390039, Russian Federation|Leningrad region clinical hospital, Saint, 194291, Russian Federation|Samara Region Clinical Hospital, Samara, 443095, Russian Federation|Federal Center of Heart, Blood and Endocrinology, Sankt-Peterburg, 197341, Russian Federation|Oncological dispensary #2, Sochi, 354057, Russian Federation|City Clinical Oncology Dispensary, St. Petersburg, 198255, Russian Federation|Clinical Research Institute of Hematology and Transfusiology, St.-Petersburg, 193024, Russian Federation|Oncology Dispensary of Komi Republic, Syktyvkar, 167904, Russian Federation|Hospital Vall d'Hebron, Barcelona N/a, 00000, Spain|Inst. Cat. Doncologia-H Duran I Reynals, L'hospitalet De Llobregat, 08907, Spain|Hosp. Univ. de La Princesa, Madrid, 28006, Spain|Hosp. Gral. Univ. Gregorio Maranon, Madrid, 28007, Spain|Hosp. Univ. Infanta Leonor, Madrid, 28031, Spain|Fundacion Jimenez Diaz, Madrid, 28040, Spain|Clinica Universitaria de Navarra, Pamplona N/a, 31008, Spain|Hospital Clinico Universitario Salamanca, Salamanca, 37007, Spain|Sahlgrenska University hospital, Hematology Dept, G?teborg, SE-413 45, Sweden|Skanes universitetssjukhus, Lund, 22185, Sweden|Karolinska Universitetssjukhuset Solna, Centrum f?r Hematologi, Stockholm, Stockholm, 171 76, Sweden|Changhua Cristian Hospital, Changhua County, 500, Taiwan|Ankara University, Ankara, 6590, Turkey|American Hospital, Istanbul, 34365, Turkey|Istanbul University, Istanbul, 34390, Turkey|Dokuz Eylul Universitesi Tip Fakultesi, Izmir, 35340, Turkey|Erciyes University, Kayseri, 38039, Turkey|Communal Nonprofit Enterprise 'Cherkasy Regional Oncology Dispensary Of Cherkasy Regional Council', Cherkasy, 18009, Ukraine|Dnepropetrovsk City Clinical Hospital #4, Regional Hematology Center, Dnepropetrovsk, 49102, Ukraine|SI Grigoriev Institute for Medical Radiology National Academy of Medical Science of Ukraine, Kharkiv, 61024, Ukraine|Khmelnitskiy Regional Hospital, Hematology Department, Khmelnitskiy, 29000, Ukraine|State Institution Scientific Center for Radiation Medicine Academy of Medical Sciences of Ukraine, Kiev, 03115, Ukraine|Institute of Blood Pathology and Transfusion Medicine of AMS of Ukraine, Lviv, 79044, Ukraine|Vinnytsya Regional Clinical Hospital named after M.I.Pirogov, Vinnitsa, 21018, Ukraine|University Hospitals Birmingham NHS Trust,, Birmingham, B15 2TH, United Kingdom|Royal Bournemouth Hospital, Bournemouth, BH7 7DW, United Kingdom|Colchester Hospital University NHS, Colchester, CO4 5JL, United Kingdom|Beatson West Of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|St James's Institute of Oncology, Leeds, LS9 7TF, United Kingdom|Leicester Royal Infirmary - Haematology, Leicester, LE1 5WW, United Kingdom|St Bartholomew's Hospital - Dept of Haematology, London, EC1A 7BE, United Kingdom|University College London Hospitals NHSFT, London, NW1 2BU, United Kingdom|Kings College Hospital, London, SE5 9RS, United Kingdom|Christie Hospital, Manchester, 00000, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|Royal Hallamshire Hospital, Sheffield, S10 2JF, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Royal Marsden Hospital (Sutton), Sutton, SM2 5PT, United Kingdom Less <<
NCT01599949 Mantle Cell Lymphoma PHASE2 COMPLETED 2025-05-15 La Jolla, California, United S... More >>tates|Los Angeles, California, United States|Stanford, California, United States|Norwalk, Connecticut, United States|Jacksonville, Florida, United States|Chicago, Illinois, United States|Peoria, Illinois, United States|Goshen, Indiana, United States|Iowa City, Iowa, United States|Sioux City, Iowa, United States|Westwood, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Worcester, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Jefferson City, Missouri, United States|Saint Louis, Missouri, United States|Omaha, Nebraska, United States|Hackensack, New Jersey, United States|New York, New York, United States|Syracuse, New York, United States|Watertown, South Dakota, United States|Nashville, Tennessee, United States|Houston, Texas, United States|Burlington, Vermont, United States|Charlottesville, Virginia, United States|Morgantown, West Virginia, United States|Madison, Wisconsin, United States|Brugge, Belgium|Gent, Belgium|Grenoble, France|Mulhouse N/A, France|Nantes, France|Pessac, France|Vandoeuvre Les Nancy, France|Afula, Israel|Beer Yaakov, Israel|Hadera, Israel|Haifa, Israel|Nahariya, Israel|Petah Tikva, Israel|Ramat Gan, Israel|Chorzow, Poland|Lodz, Poland|San Juan, Puerto Rico|Nizhny Novgorod, Russian Federation|Rostov-Na-Donu, Russian Federation|St-Petersburg, Russian Federation|St.-Petersburg, Russian Federation|Barcelona, Spain|Salamanca, Spain|London, United Kingdom|Plymouth, United Kingdom Less <<
NCT01744691 Chronic Lymphocytic Leukemia W... More >>ith 17p Deletion|Small Lymphocytic Lymphoma With 17p Deletion Less << PHASE2 COMPLETED 2025-04-16 Phoenix, Arizona, United State... More >>s|Duarte, California, United States|Greenbrae, California, United States|La Jolla, California, United States|Stanford, California, United States|Tampa, Florida, United States|Chicago, Illinois, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Rochester, Minnesota, 55905, United States|St. Louis, Missouri, United States|Hackensack, New Jersey, United States|New Hyde Park, New York, United States|New York, New York, United States|Goldsboro, North Carolina, United States|Columbus, Ohio, United States|Toldedo, Ohio, United States|Houston, Texas, United States|Adelaide, Australia|Coburg, Australia|East Melbourne, Australia|Fremantle, Australia|Antwerp, Belgium|Brugge, Belgium|Brussels, Belgium|Gent, Belgium|Kortrijk, Belgium|Leuven, Belgium|Roeselare, Belgium|Edmonton, Alberta, Canada|Cologne, Germany|Dresden, Germany|Heidelberg, Germany|Munich, Germany|Ulm, Germany|Auckland, New Zealand|Christchurch, New Zealand|Goteborg, Sweden|Lund, Sweden|Stockholm, Sweden|Ankara, Turkey|Gaziantep, Turkey|Istanbul, Turkey|Izmir, Turkey|Kayseri, Turkey|Bournemouth, United Kingdom|Glasgow, United Kingdom|Leeds, United Kingdom|Leicester, United Kingdom|Liverpool, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Newcastle upon Tyne, United Kingdom|Oxford, United Kingdom|Plymouth, United Kingdom Less <<
NCT03827603 AIHA - Warm Autoimmune Hemolyt... More >>ic Anemia Less << PHASE2 UNKNOWN 2022-03-31 Eugene Nikitin, Moscow, 125284... More >>, Russian Federation Less <<
NCT04771507 Chronic Lymphocytic Leukemia|S... More >>mall Lymphocytic Lymphoma Less << PHASE1|PHASE2 RECRUITING 2027-12-01 St Olavs Hospital, Trondheim, ... More >>7030, Norway|Falu lasarett, Falun, Dalarna, 791 82, Sweden|G?vle Hospital, G?vle, G?vleborg, 801 87, Sweden|Sk?ne University Hospital, Lund, Sk?ne, 222 42, Sweden|Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden|Karolinska University Hospital, Stockholm, 17176, Sweden|Norrland's University Hospital, Ume?, 901 85, Sweden|Akademiska hospital, Uppsala, 751 85, Sweden|?rebro University Hospital, ?rebro, 701 85, Sweden Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.35mL

2.27mL

1.14mL

22.70mL

4.54mL

2.27mL

References

 

Historical Records

Categories